Corso di laurea

medical biotechnology

Università degli studi di Bologna · 41 materie · 5 file condivisi

Il Corso di Laurea Magistrale in Medical Biotechnology è un corso biennale che fornisce al Laureato Magistrale una preparazione orientata allo svolgimento di ruoli di elevata responsabilità nella ricerca biomedica per lo sviluppo di progetti e processi in campo biotecnologico medico. Fornisce una solida conoscenza delle principali tecnologie molecolari inerenti l'uso biotecnologico di cellule procariotiche ed eucariotiche, della progettazione di strategie di ricerca con lo scopo di utilizzare le tecnologie emergenti per le applicazioni in campo medico. Una parte dell'offerta formativa è realizzata in laboratori di ricerca culturalmente all'avanguardia e dotati di strumentazione scientifica tecnologicamente avanzata in ambiti applicativi. Gli insegnamenti di questo corso di Laurea Magistrale forniscono le necessarie conoscenze delle basi molecolari e cellulari degli eucarioti superiori. Inoltre, sono fornite approfondite informazioni su specifiche funzioni cellulari dell'organismo umano, nonché competenze riguardanti i fondamenti fisiopatologici dei processi patologici a livello molecolare, cellulare e d'organo, con particolare riferimento alle patologie di interesse medico nelle quali sia possibile intervenire con approccio biotecnologico. Poiché il corso si svolgerà interamente in lingua inglese, i laureati magistrali dovranno inoltre possedere una conoscenza della lingua inglese, sia parlata che scritta, pari o superiore al livello B2 del QCER.

Il laureato in Medical Biotechnology sarà in grado di coordinare progetti di ricerca nel campo della biotecnologia e della medicina molecolare e di collaborare con i medici nello sviluppo di strategie diagnostiche e terapeutiche innovative.
Il laureato, quindi, potrà trovare impiego come:
- Ricercatore nel campo della biotecnologia medica e della medicina molecolare
- Medical Science Liaison (MSL)
- Monitor clinico
- Consulente di comunicazione medica e scientifica

Durante il Corso, gli studenti potranno partecipare a esperienze di studio e stage all'estero nell'ambito del programma Erasmus+, che rappresenta un'ottima opportunità per migliorare le proprie capacità e conoscenze in un contesto internazionale.

Proseguimento degli studi:
- Dottorato di ricerca
- Scuola di specializzazione
- Master
- per Clinical Research Associate, CRA: certificazione in accordo con DM 15 novembre 2011.

Inoltre, previo superamento dell'esame di Stato, potrà iscriversi all'Ordine professionale dei Biologi (Elenco Senior).

Presentazione del Corso di Studio

Ecco tutti i dettagli sul corso di laurea selezionato. Sul UniDocs troverai gli appunti condivisi dagli altri studenti del tuo corso di laurea, ordinati per materia. Ricordati che per poter visualizzare il materiale devi essere registrato al sito e possedere un numero di crediti sufficiente.

Al momento abbiamo 5 files caricati sul nostro portale suddivisi nelle 41 materie appartenenti al tuo corso di laurea.

Sfoglia il materiale didattico

Con UniDocs hai l'opportunità di studiare insieme a tutto il tuo corso di laurea. Guadagna subito dei crediti, carica il materiale del tuo ultimo esame!
Più condividi, più tempo avrai per studiare con tutta la community!

Materie del corso

Advanced Human Genetics (I.C.) 1° anno · 1° semestre · 0 file

Identify the major categories of inherited diseases, the genetic mechanisms contributing to disease etiology, and their inheritance patterns. Describe strategies to identify the genetic causes of inherited diseases.…

Scheda dell'insegnamento

Obiettivi formativi

Identify the major categories of inherited diseases, the genetic mechanisms contributing to disease etiology, and their inheritance patterns. Describe strategies to identify the genetic causes of inherited diseases. Discuss the use of genomic data and technology in the management of inherited diseases. Discuss innovations in human genomic research and their applications in medicine.

Programma

Module 1 (Prof. Rhoden)
Students will acquire knowledge and skills in medical genetics and genomics. Attention will be given to present recent advances described in the scientific literature which illustrate the application and impact of genomic technology on our current understanding of inherited disorders.
Specific topics include:
Introduction to genetic diseases: classes of genetic disorders; elements of genetic counselling; pedigree reconstruction; genetic testing purpose and strategies; online resources. Mendelian inheritance: review of inheritance patterns (autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive), risk of recurrence, Hardy-Weinberg principle, carrier frequency calculation. Irregularities of mendelian inheritance: de novo mutations, mosaicism, incomplete penetrance, variable expressivity, genetic and allelic heterogeneity, allelic disorders, pseudoautosomal inheritance, male lethality, X chromosome inactivation, repeat expansion. Disease examples include acondroplasia, neurofibromatosis, osteogenesis imperfecta, hearing loss, Huntington disease and Duchenne muscular dystrophy. Focus on cystic fibrosis: clinical manifestations, pathophysiology, genetics, targeted therapy Gene mapping: genetic markers, analysis of linkage, haplotype analysis, autozygosity mapping Pre-and post-genomic strategies for the indentifiction of mendelian disease genes: functional cloning, positional cloning, in silico data mining, NGS strategies Mitochondrial disorders: mitochondrial DNA, maternal inheritance, heteroplasmy and threshold effect, mitochondrial bottleneck Chromosomal abnormalities and structural variation: aneuploidy, polyploidy, structural rearrangements; contiguous gene disorders (CATCH22 deletion syndrome); structural variation, copy number variation Genomic imprinting and uniparental disomy: Angelman syndrome, Prader-Willi syndrome Multifactorial/complex inheritance: susceptibility genes, liability threshold model, familial aggregation, twin concordance, adoption studies, linkage disequilibrium, association studies, GWAS, polygenic risk score Pharmacogenetics and pharmacogenomics: variable drug responses, adverse drug reactions, pharmacogenes, drug metabolism (focus on CYP2D6), drug transport (focus on SLC1B1 and statin therapy), warfarin pharmacogenomics, genotype-guided therapy, online resources.
Module 2 Laboratory (Prof. Bonora)
Students will acquire essential knowledge and skills to design and perform molecular genetics experiments, including PCR and Sanger sequencing, to evaluate the presence of variations/mutations in human DNA and their role in Mendelian disorders.
The module will be divided into three parts: (i) lectures outlining technologies (Sanger sequencing, next generation sequencing, array CGH) and bioninformatic tools, (ii) practical wet-lab in which students will prepare PCR and sequencing reactions, and (iii) bioinformatic analysis with publicly-available programs and databases in order to analyze the obtained sequences, evaluate the presence of variants/mutations and determine their possible pathogenicity.

Modalità d'esame

Medical Genomics
Computer-based written exam using EsamiOnline with 16 multiple choice questions (5 possible answers, one correct) covering topics addressed in both Medical Genomics modules (14 questions for Module 1 + 2 questions for Module 2). Questions may include problems to be solved (e.g. interpret a pedigree; calculate the risk of recurrence, carrier frequency or recombination frequency). Calculators are allowed. Students can take the written exam twice; the highest score will be used for the final assessment of the Integrated Course.
The grade for the Integrated Course will be calculated as the mean of grades obtained in written exams for Medical Genomics and Classical and Next Generation Genomics. Three dates will be published for the official validation of Integrated Course grades (one in June, one in July, one in September); additional dates will be published if needed. Students who fail one or both written exam(s) for Medical Genomics and Classical and Next Generation Genomics must take an oral exam for the entire Integrated Course on one of three published dates. All students have the option of taking the oral exam for the Integrated Course to aim for a better grade. In this case, however, the grades obtained previously in written exams will no longer be held valid.

Testi di riferimento

Reading material will be provided online through Virtuale, including:
pdf files of lectures original research articles and reviews on selected topics
Students are also encouraged to consult the following textbooks to supplement information provided in lectures:
Human Molecular Genetics. Tom Strachan and Andrew Read. Garland Science. Thompson and Thompson Genetics in Medicine. Robert L. Nussbaum, Roderick R. McInnes, and Huntington F. Willard. Saunders/Elsevier.
Note: former editions of both textbooks will also be available on Virtuale as pdf files

Codice insegnamento 90927

Anatomical and Physiological Bases of Organ Pathologies (I.C.) 1° anno · 1° semestre · 0 file

Identify the major components and topography of the central and peripheral nervous systems. Correlate the anatomy of the nervous system with its function and pathologies. Identify the major components and topography of…

Scheda dell'insegnamento

Obiettivi formativi

Identify the major components and topography of the central and peripheral nervous systems. Correlate the anatomy of the nervous system with its function and pathologies. Identify the major components and topography of the genitourinary and reproductive systems. Identify the major endocrine glands of the body and summarize their role in the body.

Programma

CENTRAL NERVOUS SYSTEM Organization and development of the central nervous system.
Spinal cord: external and internal configuration. Spinal nerve roots. Organization of the gray substance and of the white substance. Brain Stem: bulb, pons, midbrain. External configuration and reports. Fourth ventricle, brainstem, quadrigeminal plate, mesencephalic aqueduct. Cerebellum: external and internal configuration, structure and architecture cerebellar cortex. Diencephalon: thalamus, hypothalamus, epithalamus and subthalamus. III ventricle. Telencephalon: general conformation. Fissures, lobes, gyri, cortex, brain areas. Lateral ventricles. Subcortical nuclei and organization of the white substance. Main commissural systems of the telencephalon. Limbic system. Encephalic and spinal meninges: dura mater, arachnoid, pia mater, canvas and choroid plexus, the cerebrospinal fluid. Vascularization of the neuraxis: vascularization of the spinal cord and brain. Internal carotid artery. Vertebrobasilar system. Circle of Willis. Cerebral arteries. Venous sinuses of dura mater. Autonomic nervous system: sympathetic nervous system and related complexes. Brainstem and sacral parasympathetic system.
PERIPHERAL NERVOUS SYSTEM Spinal nerves, cranial nerves and autonomous nervous system.
The Cardiovascular system and the heart
The lymphatic system and thymus, spleen, lymphonodes and MALT.
The Respiratory system: nasal cavities, larynx, trachea, lungs, ventilation.
The Digestive system: oral cavity, pharynx, oesophagus, stomach, small intestine, large intestine, liver and pancreas.
The Endocrine system: pituitary, pineal gland, thyroid, adrenal glands, endocrine pancreas.
Urinary system: kidneys and urinary bladder
Male and female reproductive system.

Modalità d'esame

The integrated course is divided into 3 modules:
Anatomy module 1 (3 CFU) Anatomy module 2 (2 CFU) Physiology (5 CFU)
Examination Timing and Session Rules: Students are required to complete all 3 modules of the examination within one solar year.
Final Grade Calculation: The final grade of the integrated course of ANATOMICAL AND PHYSIOLOGICAL BASES OF ORGAN PATHOLOGIES (I.C.) is calculated as the credit-weighted average (CFU-mediated) of the scores obtained across all modules.
Specific Details for the Anatomy Module: The Anatomy examination is oral and consists of two parts:
Program-wide Questions: Students will answer a comprehensive set of questions covering the entire anatomy syllabus
Students with learning disorders and\or temporary or permanent disabilities: please, contact the office responsible (https://site.unibo.it/studenti-con-disabilita-e-dsa/en/for-students) [(https:/site.unibo.it/studenti-con-disabilita-e-dsa/en/for-students)] as soon as possible so that they can propose acceptable adjustments. The request for adaptation must be submitted in advance (15 days before the exam date) to the lecturer, who will assess the appropriateness of the adjustments, taking into account the teaching objectives.

Testi di riferimento

Felten et al., Netter's Atlas of Neuroscience, Elsevier
Human Anatomy (9th Edition) 9th Editionby Frederic H. Martini

Codice insegnamento 91660

Anatomy 1° anno · 1° semestre · 5 CFU · BIOS-12/A · 0 file

Identify the major components and topography of the central and peripheral nervous systems. Correlate the anatomy of the nervous system with its function and pathologies. Identify the major components and topography of…

Scheda dell'insegnamento

Obiettivi formativi

Identify the major components and topography of the central and peripheral nervous systems. Correlate the anatomy of the nervous system with its function and pathologies. Identify the major components and topography of the genitourinary and reproductive systems. Identify the major endocrine glands of the body and summarize their role in the body.

Programma

CENTRAL NERVOUS SYSTEM Organization and development of the central nervous system.
Spinal cord: external and internal configuration. Spinal nerve roots. Organization of the gray substance and of the white substance. Brain Stem: bulb, pons, midbrain. External configuration and reports. Fourth ventricle, brainstem, quadrigeminal plate, mesencephalic aqueduct. Cerebellum: external and internal configuration, structure and architecture cerebellar cortex. Diencephalon: thalamus, hypothalamus, epithalamus and subthalamus. III ventricle. Telencephalon: general conformation. Fissures, lobes, gyri, cortex, brain areas. Lateral ventricles. Subcortical nuclei and organization of the white substance. Main commissural systems of the telencephalon. Limbic system. Encephalic and spinal meninges: dura mater, arachnoid, pia mater, canvas and choroid plexus, the cerebrospinal fluid. Vascularization of the neuraxis: vascularization of the spinal cord and brain. Internal carotid artery. Vertebrobasilar system. Circle of Willis. Cerebral arteries. Venous sinuses of dura mater. Autonomic nervous system: sympathetic nervous system and related complexes. Brainstem and sacral parasympathetic system.
PERIPHERAL NERVOUS SYSTEM Spinal nerves, cranial nerves and autonomous nervous system.
The Cardiovascular system and the heart
The lymphatic system and thymus, spleen, lymphonodes and MALT.
The Respiratory system: nasal cavities, larynx, trachea, lungs, ventilation.
The Digestive system: oral cavity, pharynx, oesophagus, stomach, small intestine, large intestine, liver and pancreas.
The Endocrine system: pituitary, pineal gland, thyroid, adrenal glands, endocrine pancreas.
Urinary system: kidneys and urinary bladder
Male and female reproductive system.

Modalità d'esame

The integrated course is divided into 3 modules:
Anatomy module 1 (3 CFU) Anatomy module 2 (2 CFU) Physiology (5 CFU)
Examination Timing and Session Rules: Students are required to complete all 3 modules of the examination within one solar year.
Final Grade Calculation: The final grade of the integrated course of ANATOMICAL AND PHYSIOLOGICAL BASES OF ORGAN PATHOLOGIES (I.C.) is calculated as the credit-weighted average (CFU-mediated) of the scores obtained across all modules.
Specific Details for the Anatomy Module: The Anatomy examination is oral and consists of two parts:
Program-wide Questions: Students will answer a comprehensive set of questions covering the entire anatomy syllabus
Students with learning disorders and\or temporary or permanent disabilities: please, contact the office responsible (https://site.unibo.it/studenti-con-disabilita-e-dsa/en/for-students) [(https:/site.unibo.it/studenti-con-disabilita-e-dsa/en/for-students)] as soon as possible so that they can propose acceptable adjustments. The request for adaptation must be submitted in advance (15 days before the exam date) to the lecturer, who will assess the appropriateness of the adjustments, taking into account the teaching objectives.

Testi di riferimento

Felten et al., Netter's Atlas of Neuroscience, Elsevier
Human Anatomy (9th Edition) 9th Editionby Frederic H. Martini

Codice insegnamento 90922

BIOMOLECULAR BASIS OF ANATOMICAL PATHOLOGY [cod. 90932] 1° anno · 1 file
Biomolecular Basis of Anatomical Pathology 1° anno · 2° semestre · 6 CFU · MEDS-04/A · 0 file

Discuss the principal epidemiologic, morphologic, phenotypic, clinicopathologic features, and etiopathogenesis of common neoplastic and non neoplastic disorders, focusing on cardiovascular and neuromuscolar disorders.…

Scheda dell'insegnamento

Obiettivi formativi

Discuss the principal epidemiologic, morphologic, phenotypic, clinicopathologic features, and etiopathogenesis of common neoplastic and non neoplastic disorders, focusing on cardiovascular and neuromuscolar disorders. Describe the methods used to process and analyze tissue samples for diagnostic Anatomic Pathology, including histopathology and ultrastructural laboratory instrumentation and devices. Discuss innovative technologies for early diagnosis of disease, and for the identification of new molecular targets for tumor therapies.

Programma

Definition of Anatomic Pathology
· Methods and Techniques in Anatomic Pathology
· Tumor classification
· Tumor of Central Nervous System and of pituitary: pathology and molecular diagnostics
· Neurodegenerative diseases: pathology and molecular diagnostics
· Neuromuscular diseases: muscle pathology
· Ultrastructural diagnostic (Electron microscopy) and ultrastructural markers in Tumor diagnosis
· Molecular diagnostic and prognostic markers in solid tumors
· Tumors of the respiratory system: pathology and molecular diagnostics
· Tumors of gastroenteropancreatic system: pathology and molecular diagnostics
· Tumors of the female reproductive system: pathology and molecular diagnostics
· Tumors of the endocrine and neuro-endocrine system: pathology and molecular diagnostics
The course will include 1 CFU of practical activity (Laboratory) through viewing and discussion of slides and interpretation of molecular data.

Modalità d'esame

The student will be evaluated after oral examination about:
1. General principles of Anatomic Pathology and Molecular Diagnostics (Techniques and methodology)
2. Histopathological and molecular features of solid tumors
3. Discussion of cases

Testi di riferimento

Kumar, Cotran, Robbins "Basic Pathology", Saunders eds
World Health Classification of Central Nervous System Tumor 2021 5ed.

Codice insegnamento 90932

Biomolecular Basis of Organ Pathologies (I.C.) 1° anno · 2° semestre · 0 file

Describe the molecular basis of endocrine systems and the pathogenesis of endocrine diseases. Discuss the development and application of novel technological strategies for the diagnosis and therapy of endocrinological…

Scheda dell'insegnamento

Obiettivi formativi

Describe the molecular basis of endocrine systems and the pathogenesis of endocrine diseases. Discuss the development and application of novel technological strategies for the diagnosis and therapy of endocrinological disesases in the daily clinical practice. Critically read and interpret scientific literature in the field of endocrinology and metabolism.

Programma

PROGRAMMA 1) Il sistema endocrino: generalità, funzioni del sistema endocrino, classificazione degli ormoni.
2) Gli assi endocrini e le ghiandole bersaglio.
3) Regolazione del controllo alimentare. Il sistema omeostatico e il sistema edonistico. Tessuto adiposo. Obesità monogenica. Cause endocrine di obesità. Sindrome metabolica. L'obesità nei roditori e metodologie per valutarla.
4) Le basi del metabolismo glucidico, iperinsulinismo e sue conseguenze, diabete tipo 1 e tipo 2. Cenni di terapia del diabete di tipo 2. Farmaci derivati dal GLP-1, GIP e glucagone.
5) Basi molecolari dei tumori tiroidei e paratiroidei.
6) Basi molecolari della formazione degli adenomi surrenalici.
7) Basi molecolari dei tumori ipofisari.
8) Basi molecolari per l'impiego della somatostatina nei tumori neuroendocrini.
9) Gli interferenti del sistema endocrino e tecnologie di studio.
10) Metodologie analitiche per la misurazione degli ormoni.

Modalità d'esame

L'esame è orale.
Il voto deriva dalla media dei voti ottenuti da tutti i docenti del Corso Integrato.

Testi di riferimento

Solo a sussidio delle lezioni si consiglia per una overview generale il libro:
"Core curriculum Endocrinologia e Metabolismo" di Faglia G, Beck-Peccoz P, Spada A, Lania A. Editore: Mc Graw-Hill 2009 1° edizione.

Codice insegnamento 90937

CLASSICAL AND NEXT-GENERATION GENOMICS [cod. 90929] 1° anno · 1 file
ENDOCRINOLOGY [cod. 69887] 1° anno · 1 file
Emerging Molecular Biology in Health and Disease 1° anno · 2° semestre · 6 CFU · BIOS-08/A · 0 file

Describe general overviews on stem cell biology Identify the most important solutions and problems arising from some of the most advanced views in cellular signaling, genome function and cellular reprogramming.…

Scheda dell'insegnamento

Obiettivi formativi

Describe general overviews on stem cell biology Identify the most important solutions and problems arising from some of the most advanced views in cellular signaling, genome function and cellular reprogramming. Identify when progression in basic and translational research can effectively match unmet clinical needs Discuss the mechanisms underlying cell growth and differentiation, with particular reference to the modulation of gene expression, epigenetics, nuclear dynamics and signaling. Critically explain the future perspectives in Regenerative and Precision Medicine. Evaluate the most updated publications within the context of Molecular and Cellular Biology, with particular emphasis to mechanisms underlying cellular commitment and adaptation, reprogramming, and differentiation.

Programma

Foundations of biomedical research and molecular biology

  • The scientific method in biomedical research. The scientific method: observation, hypothesis, experimentation, data analysis, and theory building. Experimental design and reproducibility. Controls, bias, and statistical significance. Translational research pipeline: from basic discovery to clinical application. From bench to bedside and back.
  • Types, structure and critical evaluation of a scientific articles. Types of scientific articles. Scientific original article sections: abstract, introduction, methods, results, discussion. The peer review process. Journal impact factors. How to search for scientific papers.
  • DNA Structure, function and regulation: from discovery to modern concepts. The identification of DNA as the hereditary material. The discovery of the double helix and base-pairing rules. The establishment of the central dogma of molecular biology. Overview of major discoveries regarding DNA manipulation, biotechnology, gene regulation, genomics, precision and systems biology.
    Embryonic and induced pluripotent stem cells
  • Embryonic stem cells (ESC) and induced pluripotent stem cells (IPS). Comparison of embryonic and adult stem cells in terms of potency and differentiation potential. Principles of somatic cell reprogramming to generate induced pluripotent stem cells. Role of key transcription factors in lineage commitment and differentiation. Examples of stem cell differentiation both in vivo during embryonic organ development and in vitro from ESCs/IPS into specific cell types. Transplantation of IPS-derived differentiated cells, and direct reprogramming (transdifferentiation) of somatic cells into specific cell types as regenerative strategies.
    Gene editing and molecular tools for constitutive, transient and time-controlled gene expression
  • Conventional and conditional gene editing. Overview of DNA repair mechanism. Double-strand DNA breaks (DSBs) repair by homologous and non-homologous recombination. Generation of conventional knock-out (KO) and knock-in (KI) strategies. Engineered nucleases. DNA recombinases. Cre-Lox system for tissue-specific knock-out and knock-in. Temporal control of gene manipulation by inducible Cre recombinase. Combination of multiple recombinases for sophisticated manipulations. Tet-OFF/Tet-ON systems for inducible, tissue-specific, and time-controlled gene expression.
  • Approaches to manipulate gene expression in humans. Plasmids. Viral vectors (retroviruses, lentiviruses, adenoviruses, adeno-associated viruses - AAVs). Peptides/proteins and antibodies. Emerging RNA-based therapeutics (miRNA, antagomir and siRNA, modified mRNA).
    Tissue renewal, adult stem cells and their application as regenerative therapies.
  • Tissue renewal and its analysis: cell cycle, proliferation and cellular sources. Renewal capacities across tissues and organs. Overview of the cell cycle, checkpoints and regulation. Methods for measuring proliferation, including analysis of markers (i.e. Ki67, phospho-H3…), and nucleoside analogue incorporation assay (i.e. BrdU). Analysing cellular sources of regeneration via lineage tracing.
  • Regeneration capabilities across species: lessons from spontaneously regenerating animal models. Comparative analysis of regenerative mechanisms in model organisms and implications for human therapies.
  • Highly renewing tissues: continuous turnover under normal conditions and robust regeneration in response to injury thanks to resident stem cell populations. Examples: blood, skin, intestinal epithelium, and corneal epithelium.
    Overview of blood. Hematopoietic stem cells (HSC). HSC niches and regulatory mechanisms. Clinical applications of HSC mobilization and transplantation. HSC gene therapies.
    Overview of the skin. Skin stem cell populations and their contribution to different skin lineages. Skin transplantation. Skin stem cells gene therapies.
    Overview of the intestine. Adult intestinal Stem Cells. Main regulatory signals and their sources in the intestinal crypt.
    Overview of cornea. Cornea stem cells (limbal cells). Corneal regeneration by transplantation of limbal stem cells.
  • Stable tissues: limited turnover under normal conditions but robust regeneration in response to injury. Examples: skeletal muscle, liver and kidney tubules.
    Overview of skeletal muscles. Adult Stem Cells in skeletal muscle: the satellite cells. Satellite cell niche. Quiescence to proliferation transition in satellite cells.
    Overview of the liver. Cellular and molecular mechanisms of hepatocytes dedifferentiation during liver regeneration.
    Overview of the kidneys. Minimal to no turnover and regeneration of glomerular cell components. Tubular epithelial cell regeneration by injury-induced dedifferentiation and proliferation of surviving mature cells.
  • Permanent tissues: limited or absent turnover under normal conditions and limited or absent regeneration in response to injury. Examples: the brain, skeletal muscle and the heart.
    Overview of the brain. Evaluation of brain tissue renewal with 14C incorporation. Neural stem cells during brain development and adult neurogenesis. Brain neurogenic niches in adult individuals. Preclinical and clinical studies for neuronal regeneration.
    Overview of the heart. Evaluation of heart tissue renewal with 14C incorporation. Clinical trials for cardiac regeneration based on adult stem cells. Cardiac progenitors during prenatal development. Controversies on adult cardiac stem cells and the emerging consensus based on lineage tracing. Discussion of the modest efficacy of adult stem cell therapies for cardiac regeneration. Developmental regulation of heart regeneration in mammals: lessons from developmental biology. Mature cell dedifferentiation: molecular mechanisms and therapeutic potential. Role of cell dedifferentiation in tissue regeneration.

Modalità d'esame

The students will be evaluated by written exam.
The written test consists of 31 multiple-choice questions, with only one correct answer per question. Students will receive 1 point for each correct answer, and 0 points for incorrect or missing answers.
The time available to students for the written test is 30 minutes. During the test, the use of support materials, such as textbooks, notes, computer supports, is not allowed. The maximum score obtainable by providing all correct answers is equal to 30 cum laude. The test is considered passed with a minimum score of 18/30.
To improve their final grade of the written exam, students may opt for an oral exam. This consists of a brief presentation of a scientific article, followed by a critical discussion of the article itself and of topics addressed during the course.
⚠️ Please note that the final grade may be adjusted upward or downward based on the outcome of the oral exam.

Testi di riferimento

All teaching materials presented during the lectures will be made available to students through the Virtual Learning Environment platform [https://virtuale.unibo.it/ ].
For further study, students are free to use any Molecular Biology textbook, in either Italian or English. By way of example, the following volumes are recommended:
Iwasa and Marshall – Karp’s Cell and Molecular Biology: Concepts and Experiments – Ninth Edition
Krebs et al. - Lewin's Essential GENES
Krebs et al. - Lewin's GENES XII
Clark et al - Molecular Biology
Lodish et al - Molecular Cell Biology
Watson et al. - Molecular biology of the gene
Albert et al. - Molecular Biology Of The Cell

Codice insegnamento 90926

Endocrinology 1° anno · 2° semestre · 3 CFU · MEDS-08/A · 0 file

Describe the molecular basis of endocrine systems and the pathogenesis of endocrine diseases. Discuss the development and application of novel technological strategies for the diagnosis and therapy of endocrinological…

Scheda dell'insegnamento

Obiettivi formativi

Describe the molecular basis of endocrine systems and the pathogenesis of endocrine diseases. Discuss the development and application of novel technological strategies for the diagnosis and therapy of endocrinological disesases in the daily clinical practice. Critically read and interpret scientific literature in the field of endocrinology and metabolism.

Programma

1) The endocrine system: function, classification.
2) The endocrine axes and the target organs.
3) Food intake control. The homeostatic and hedonic control of food intake. The adipose tissue organ. Monogenic obesity. Endocrine causes of obesity. Metabolic syndrome. Obesity in rodents and its lab evaluation.
4) The basis of glicidic metabolism. Hyperinsulinism and its consequences. Type 1 and 2 diabetes mellitus. Type 2 diabetes therapy. GLP-1, GIP and glucagone derived drugs.
5) Molecular basis of thyroid and parathyroid tumors.
6) Molecular basis of adrenal adenomas.
7) Molecular basis of pituitary adenomas
8) Molecular basis of the somatostatin use in the treatment of the neuroendocrine tumors.
9) Endocrine disruptors and technological approaches to their study.
10) Analytical methodologies for hormone measurement.

Modalità d'esame

The assessment is in oral form.
The final note derives from the mean of the single notes obtained by all the Professors of the Integrated Course.

Testi di riferimento

Only as a further confirmation or as a general overview we suggest the following book:
"Core curriculum Endocrinologia e Metabolismo" di Faglia G, Beck-Peccoz P, Spada A, Lania A. Editore: Mc Graw-Hill 2009 1° edizione.

Codice insegnamento 69887

HUMAN GENOMICS 1° anno · 1° semestre · 5 CFU · BIOS-10/A · 0 file

Discuss the structure, organization, variability, genetic information and gene families of the human genome. Critically appraise the rational basis of the main molecular and computational biology methods used for the…

Scheda dell'insegnamento

Obiettivi formativi

Discuss the structure, organization, variability, genetic information and gene families of the human genome. Critically appraise the rational basis of the main molecular and computational biology methods used for the study of genomes, including both classical and next-generation approaches. Consult and study bibliographic sources to self-update on innovative genomic topics and techniques. Use common software tools for genetics and genomics, and apply them to the biomedical field.

Programma

1. Human Genomics and Post-Genomics
2. Bibliography and Genomics databases
3. Methods for studying nucleic acid
4. Nucleic Acids Hybridization (Southern Blot, Northern Blot, Microarray)
5. Polymerase Chain Reaction (Kinetics, Parameters, Design)
6. cDNA, EST and genomic Libraries
7. Nucleic Acids Sequencing and Sequence Analysis
8. Computational and System Biology - Trisomy 21
Laboratory (15 hours)
1. Advanced use of bibliography and genomics databanks
2. Gene structure - NCBI Gene database
3. PCR primer design
4. Sequence analysis
5. Documentary and discussion

Modalità d'esame

16 multiple choice questions on the treated topics, in person. Attendance to learning activities is mandatory; the minimum attendance requirement to be admitted to the final exam is 60% of lessons and laboratories.

Testi di riferimento

Website: http://apollo11.isto.unibo.it/
Website: http://apollo11.isto.unibo.it/biotech/en/Biotech.htm
Teaching materials will be made available through both public websites and Student access to the "Virtuale" platform.

Codice insegnamento C8539

Human Embriology 1° anno · 2° semestre · 3 CFU · BIOS-13/A · 0 file

Describe the mechanisms that control embryogenesis and morphogenesis in relation to human abnormalities and malformations. Discuss the mechanisms underlying embryonic processes focusing on recent discoveries that have…

Scheda dell'insegnamento

Obiettivi formativi

Describe the mechanisms that control embryogenesis and morphogenesis in relation to human abnormalities and malformations. Discuss the mechanisms underlying embryonic processes focusing on recent discoveries that have shed light on traditional concepts or raised new doubts. Critically evaluate issues related to embryonic and adult stem cells. Describe the methods for stem cell isolation to obtain progenitor cells from perinatal tissues.

Programma

Introduction to human development
Reproductive organs Femal Reproductive Cycles: ovarian cycle and menstrual cycle Transportation of Gametes: oocyte transport and sperm transport and maturation Viability of oocytes and sperms
First week of human development
Fertilization Phases of fertilization Cleavage of zygote Formation of Blastocyst
Second week of human development
Formation of amniotic cavity, embryonic disc and umbilical vesicle Development of Chorionic Sac Implantation sites of Blastocystes
Third week of human development
Gastrulation: formation of germs layers Neurulation: formation of the neural tube Development of Somites Development of Intraembryonic coelom Early development of cardiovascular system, example of regeneration Development of Chorionic Villi
Fourth Week of human development
Folding of Embryo Head and Tail Folds Lateral Folds Germ Layer Derivatives Control of Embryonic Development Estimation of Embryonic Age
Placenta and fetal membranes
Decidua Development of Placenta Fetomaternal junction Intervillous Space Amniochorionic Membrane Placental Circulation Stages of Labor Placenta and Fetal Membranes after Birth Umbelical Cord Amnion and amniotic fluid Umbelical vesicle Fetal Membranes
Principles and Mechanisms of Morphogenesis
Animal models Patterning the vertebrate embryo Oogenesis, embryonic development, and offspring from female iPSC-derived PGCLCs. Self-Organization of the in vitro attached human embryo Ex utero mouse embryogenesis from pre-gastrulation to late organogenesis

Modalità d'esame

The students will be evaluated by oral exam.

Testi di riferimento

Human Embryology and Developmental Biology
Bruce Carlson, Elsevier
Before we are Born, Essential of Embryology and Birth Defects
Keith.L. Moore, T.V.N. Persaud, Mark G. Torchia. Elsevier
Articles provided during the frontal lessons

Codice insegnamento 90934

Internal Medicine 1° anno · 2° semestre · 3 CFU · MEDS-05/A · 0 file

Describe the pathophysiological bases of human diseases with specific emphasis on oncological, degenerative metabolic and immunological conditions, focusing on cellular and molecular etiopathogenetic mechanisms of…

Scheda dell'insegnamento

Obiettivi formativi

Describe the pathophysiological bases of human diseases with specific emphasis on oncological, degenerative metabolic and immunological conditions, focusing on cellular and molecular etiopathogenetic mechanisms of clinical relevance; Identify pathological conditions in which biotechnological approaches are already of clinical relevance; Select and interpret information in order to collaborate with medical practitioners in designing and applying biotechnological diagnostic and therapeutic strategies; Plan, implement and develop potential applications of biotechnology in the field of Internal Medicine, in order to operate in biomedical research

Codice insegnamento 65226

LABORATORY TECHNIQUES IN BIOMEDICAL SCIENCES 1° anno · 2° semestre · 2 CFU · MEDS-26/A · 0 file

Describe the steps of a protocol for the immunofluorescence/immunohistochemistry labelling of immune cells in paraffin-embedded tissues.

Scheda dell'insegnamento

Obiettivi formativi

Describe the steps of a protocol for the immunofluorescence/immunohistochemistry labelling of immune cells in paraffin-embedded tissues.

Programma

This is a practical laboratory course in which students will perform an immunofluorescence assay for the labeling of immune cells.
Students will gain knowledge of the immunofluorescence protocol. The rationale behind the protocol, as well as its technical steps, will be presented during the practical laboratory session. In addition, the biological characteristics and functions of mast cells, together with examples of diseases in which these immune cells play a significant role, will be explored.

Modalità d'esame

Attendance is mandatory. Students who do not meet the minimum laboratory attendance requirement of 60% will not be eligible to take the examination for the integrated course.

Testi di riferimento

Lecture slides will be made available online via Virtuale. The experimental protocol will be provided to students before the hands-on laboratory session.

Codice insegnamento C8540

MOLECULAR ONCOLOGY AND IMMUNOPATHOLOGY [cod. 76168] 1° anno · 1 file
Medical Genomics- 1° anno · 1° semestre · 5 CFU · MEDS-01/A · 0 file

Identify the major categories of inherited diseases, the genetic mechanisms contributing to disease etiology, and their inheritance patterns. Describe strategies to identify the genetic causes of inherited diseases.…

Scheda dell'insegnamento

Obiettivi formativi

Identify the major categories of inherited diseases, the genetic mechanisms contributing to disease etiology, and their inheritance patterns. Describe strategies to identify the genetic causes of inherited diseases. Discuss the use of genomic data and technology in the management of inherited diseases. Discuss innovations in human genomic research and their applications in medicine.

Programma

Module 1 (Prof. Rhoden)
Students will acquire knowledge and skills in medical genetics and genomics. Attention will be given to present recent advances described in the scientific literature which illustrate the application and impact of genomic technology on our current understanding of inherited disorders.
Specific topics include:
Introduction to genetic diseases: classes of genetic disorders; elements of genetic counselling; pedigree reconstruction; genetic testing purpose and strategies; online resources. Mendelian inheritance: review of inheritance patterns (autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive), risk of recurrence, Hardy-Weinberg principle, carrier frequency calculation. Irregularities of mendelian inheritance: de novo mutations, mosaicism, incomplete penetrance, variable expressivity, genetic and allelic heterogeneity, allelic disorders, pseudoautosomal inheritance, male lethality, X chromosome inactivation, repeat expansion. Disease examples include acondroplasia, neurofibromatosis, osteogenesis imperfecta, hearing loss, Huntington disease and Duchenne muscular dystrophy. Focus on cystic fibrosis: clinical manifestations, pathophysiology, genetics, targeted therapy Gene mapping: genetic markers, analysis of linkage, haplotype analysis, autozygosity mapping Pre-and post-genomic strategies for the indentifiction of mendelian disease genes: functional cloning, positional cloning, in silico data mining, NGS strategies Mitochondrial disorders: mitochondrial DNA, maternal inheritance, heteroplasmy and threshold effect, mitochondrial bottleneck Chromosomal abnormalities and structural variation: aneuploidy, polyploidy, structural rearrangements; contiguous gene disorders (CATCH22 deletion syndrome); structural variation, copy number variation Genomic imprinting and uniparental disomy: Angelman syndrome, Prader-Willi syndrome Multifactorial/complex inheritance: susceptibility genes, liability threshold model, familial aggregation, twin concordance, adoption studies, linkage disequilibrium, association studies, GWAS, polygenic risk score Pharmacogenetics and pharmacogenomics: variable drug responses, adverse drug reactions, pharmacogenes, drug metabolism (focus on CYP2D6), drug transport (focus on SLC1B1 and statin therapy), warfarin pharmacogenomics, genotype-guided therapy, online resources.
Module 2 Laboratory (Prof. Bonora)
Students will acquire essential knowledge and skills to design and perform molecular genetics experiments, including PCR and Sanger sequencing, to evaluate the presence of variations/mutations in human DNA and their role in Mendelian disorders.
The module will be divided into three parts: (i) lectures outlining technologies (Sanger sequencing, next generation sequencing, array CGH) and bioninformatic tools, (ii) practical wet-lab in which students will prepare PCR and sequencing reactions, and (iii) bioinformatic analysis with publicly-available programs and databases in order to analyze the obtained sequences, evaluate the presence of variants/mutations and determine their possible pathogenicity.

Modalità d'esame

Medical Genomics
Computer-based written exam using EsamiOnline with 16 multiple choice questions (5 possible answers, one correct) covering topics addressed in both Medical Genomics modules (14 questions for Module 1 + 2 questions for Module 2). Questions may include problems to be solved (e.g. interpret a pedigree; calculate the risk of recurrence, carrier frequency or recombination frequency). Calculators are allowed. Students can take the written exam twice; the highest score will be used for the final assessment of the Integrated Course.
The grade for the Integrated Course will be calculated as the mean of grades obtained in written exams for Medical Genomics and Classical and Next Generation Genomics. Three dates will be published for the official validation of Integrated Course grades (one in June, one in July, one in September); additional dates will be published if needed. Students who fail one or both written exam(s) for Medical Genomics and Classical and Next Generation Genomics must take an oral exam for the entire Integrated Course on one of three published dates. All students have the option of taking the oral exam for the Integrated Course to aim for a better grade. In this case, however, the grades obtained previously in written exams will no longer be held valid.

Testi di riferimento

Reading material will be provided online through Virtuale, including:
pdf files of lectures original research articles and reviews on selected topics
Students are also encouraged to consult the following textbooks to supplement information provided in lectures:
Human Molecular Genetics. Tom Strachan and Andrew Read. Garland Science. Thompson and Thompson Genetics in Medicine. Robert L. Nussbaum, Roderick R. McInnes, and Huntington F. Willard. Saunders/Elsevier.
Note: former editions of both textbooks will also be available on Virtuale as pdf files

Codice insegnamento 81594

Molecular Basis of Haematological Disorders 1° anno · 2° semestre · 3 CFU · MEDS-09/B · 0 file

Describe the biological properties of the hematopoietic stem cells and relevant biotechnological applications. Describe the phenotype and genotype of hematological malignancies. Discuss the principles of targeted therapy…

Scheda dell'insegnamento

Obiettivi formativi

Describe the biological properties of the hematopoietic stem cells and relevant biotechnological applications. Describe the phenotype and genotype of hematological malignancies. Discuss the principles of targeted therapy and cell therapy with particular reference to the transplantation of stem cells and regenerative medicine. Define the molecular targets and cellular structures suitable for the development of new forms of targeted therapy. Critically evaluate new diagnostic and therapeutic approaches in hematology.​

Programma

Hematopoiesis.
Normal and leukemic stem cells and their niche.
Clonal hematopoiesis and pre-leukemic states.
Mechanisms of leukemogenesis.
Molecular bases of acute leukemias.
Molecular bases of chronic myeloproliferative neoplasias.
Molecular bases of lymphoid malignancies.
Principles of targeted therapy.
Mechanisms of resistance to target therapy.

Modalità d'esame

Oral exam at the end of the course, upon registration.
The oral exam will consist of two questions.
The final exam aims to evaluate the achievement of the educational objectives:

  • To know the biomolecular bases of normal and leukemic hemopoiesis
  • To understand the design of an experimental research plan and to critically evaluate experimental results.
    The final grade of the Integrated Course is based on the average of the scores reported on topics related to the main objectives of the Course.

Testi di riferimento

"Hematology-Pathophysiology, Diagnosis and Treatment" S. Tura, M. Cavo, PL. Zinzani-Società Editrice Esculapio Bologna.
In addition, specific recent bibliography and web resources will be indicated.

Codice insegnamento 90936

Molecular Oncology and Immunopathology 1° anno · 2° semestre · 6 CFU · MEDS-02/A · 0 file

Describe the transformed phenotype and its molecular and cellular basis, the pathogenesis of cancer, including the interactions with the microenvironment and the immune system, and molecular cancer progression up to…

Scheda dell'insegnamento

Obiettivi formativi

Describe the transformed phenotype and its molecular and cellular basis, the pathogenesis of cancer, including the interactions with the microenvironment and the immune system, and molecular cancer progression up to the metastatic diffusion. Identify the phases of development and the tumor types relevant to human oncology and define molecular targets for innovative targeted therapies. Discuss the pathogenetic mechanisms of the main immune pathologies (immunodeficiencies, allergy, autoimmunity), as well as the role of the immune system in the natural and vaccine-elicited immunity to infectious agents, cell and organ transplants, and cancer.

Programma

CANCER BIOLOGY AND MOLECULAR ONCOLOGY
Introduction to cancer biology: definition, classification, and terminology. Epidemiology and risk factors of cancer. Oncogenes, tumor suppressor genes. Hereditary tumors. Tumor heterogeneity and clonal evolution. Tumor immunology. Hallmarks of cancer: angiogenesis, tumor microenvironment, immune evasion, metastasis, cancer metabolism, replicative immortality. Mechanisms of carcinogenesis: physical, chemical, biological. Cancer prevention: primary and secondary prevention, chemoprevention. Clinical implications: paraneoplastic syndromes and cancer cachexia. Fundamentals and molecular and biological mechanisms of radiation, pharmacological, biological, immunological, and gene therapies for cancer.
MOLECULAR IMMUNOPATHOLOGY
General mechanisms of immunopathology Hypersensitivity reactions Autoimmune diseases Primary and secondary immunodeficiencies Transplantation immunology Translational immunopathology and emerging technologies

Modalità d'esame

Student learning will be assessed through an oral examination designed to evaluate the achievement of the course learning objectives and, in particular, the acquisition of the fundamental concepts of Molecular Oncology and Molecular Immunopathology.
The examination aims to assess students' ability to apply their knowledge and to integrate concepts through logical and critical reasoning.
The minimum passing grade is 18/30.
Students with specific learning disorders (SLD), temporary or permanent disabilities, or other special educational needs are invited to contact the dedicated University office (https://site.unibo.it/studenti-con-disabilita-e-dsa/it/per-studenti) as early as possible so that appropriate accommodations can be arranged. Requests must be submitted to the course instructor at least 15 days before the examination date. The instructor will evaluate the requested accommodations, taking into account the learning objectives of the course.
Final Grade Scale
Fail (<18/30): Inadequate preparation, characterized by significant gaps in knowledge and serious, repeated conceptual errors.
18–19/30: Adequate knowledge of the fundamental concepts without major deficiencies. Overall acceptable presentation and use of scientific terminology.
20–24/30: Sound knowledge of the fundamental concepts. Partial ability to analyze and integrate information independently. Clear presentation and appropriate scientific language.
25–29/30: Good to very good preparation, or excellent preparation with minor inaccuracies in presentation that prevent the highest grade. Ability to analyze and integrate concepts independently. Logical organization of concepts and good command of scientific terminology.
30–30 cum laude: Comprehensive, well-established, and accurate knowledge of all course topics. Excellent ability to frame and discuss scientific issues, analyze and integrate concepts independently, and present information clearly with complete mastery of the appropriate scientific terminology.

Testi di riferimento

Lecture slides
Recommended texts:
Weinberg The Biology of Cancer, Second Edition. P-L Lollini – Cellular and molecular oncology (open access book available in Virtuale website) Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. Latest edition. Elsevier Consultation: Pardi e Di Fiore, Patogenesi. Ed. Piccin R G.M. Pontieri, Patologia generale e fisiopatologia generale. Vol. 1, VI edizione (2018) ed. Piccin Robbins & Cotran Pathologic Basis of Disease 9th edition Rubin’s Pathology 7th, Wolters Kluwer ed

Codice insegnamento 76168

Nephrology 1° anno · 2° semestre · 3 CFU · MEDS-08/B · 0 file

Describe the normal architecture and function of the renal parenchyma, and the molecular and cellular etiopathogenesis of the main nephrological diseases. Discuss the main diagnostic techniques for the identification…

Scheda dell'insegnamento

Obiettivi formativi

Describe the normal architecture and function of the renal parenchyma, and the molecular and cellular etiopathogenesis of the main nephrological diseases. Discuss the main diagnostic techniques for the identification of diseases with renal involvement. Discuss innovative biotechnological strategies for the diagnosis and therapy of renal disorders. Apply molecular biology techniques for the study of nephrological problems.

Programma

Clinical Nephrology area of interests in biotechnology
(immunological glomerulopathies, hereditary nephropathies, biomarkers of acute kidney injury, acute renal failure, chronic renal failure, hemodialysis, kidney transplantation)

Modalità d'esame

Oral exams

Testi di riferimento

Updated teaching material is provided in class.
The teaching material presented in class will be made available to the student in electronic format available online Virtually.

Codice insegnamento 69883

Normal and Leukemic Stem Cells (I.C.) 1° anno · 2° semestre · 0 file

Describe the mechanisms that control embryogenesis and morphogenesis in relation to human abnormalities and malformations. Discuss the mechanisms underlying embryonic processes focusing on recent discoveries that have…

Scheda dell'insegnamento

Obiettivi formativi

Describe the mechanisms that control embryogenesis and morphogenesis in relation to human abnormalities and malformations. Discuss the mechanisms underlying embryonic processes focusing on recent discoveries that have shed light on traditional concepts or raised new doubts. Critically evaluate issues related to embryonic and adult stem cells. Describe the methods for stem cell isolation to obtain progenitor cells from perinatal tissues.

Programma

Introduzione allo sviluppo umano
Organi riproduttivi
Cicli riproduttivi femminili: ciclo ovarico e ciclo mestruale
Trasporto dei gameti: trasporto e maturazione dell'ovocita e degli spermatozoi
Vitalità degli ovociti e degli spermatozoi
Prima settimana dello sviluppo umano
Fecondazione Fasi della fecondazione Clivaggio dello zigote Formazione della blastocisti
Seconda settimana dello sviluppo umano
Formazione della cavità amniotica, del disco embrionale e della vescicola ombelicale Sviluppo del sacco corionico Siti di impianto della blastocisti
Terza settimana dello sviluppo umano
Gastrulazione: formazione degli strati germinativi Neurulazione: formazione del tubo neurale Sviluppo dei somiti Sviluppo del celoma intraembrionale Primo sviluppo del sistema cardiovascolare, esempio di rigenerazione Sviluppo delle villi coriali
Quarta settimana dello sviluppo umano
Ripiegamento dell'embrione Ripiegamento della testa e della coda Piega laterale Derivati degli strati germinativi Controllo dello sviluppo embrionale Stima dell'età embrionale
Placenta e membrane fetali
Decidua Sviluppo della placenta Membrana amnio-corionica Circolazione placentare Placenta e membrane fetali dopo il parto Cordone ombelicale Amnios e liquido amniotico Vescicola ombelicale Membrane fetali
Principi e meccanismi di morfogenesi
Modelli animali Organizzazione del mesoderma embrionale Oogenesi, sviluppo embrionale e progenie da PGCLC derivate da iPSC femminili Auto-organizzazione dell'embrione umano in vitro Embriogenesi di topo ex utero dalla pre-gastrulazione alla tarda organogenesi

Modalità d'esame

Gli studenti saranno valutati con un esame orale

Testi di riferimento

Human Embryology and Developmental Biology
Bruce Carlson, Elsevier
Before we are Born, Essential of Embryology and Birth Defects
Keith.L. Moore, T.V.N. Persaud, Mark G. Torchia. Elsevier
Articoli forniti durante le lezioni frontali

Codice insegnamento 90933

Physiology 1° anno · 1° semestre · 5 CFU · BIOS-06/A · 0 file

Identify the morphology and function of specific organs and apparatuses of biotechnological interest in the context of clinical applications. Correlate concepts of integrative physiology of the human organism with…

Scheda dell'insegnamento

Obiettivi formativi

Identify the morphology and function of specific organs and apparatuses of biotechnological interest in the context of clinical applications. Correlate concepts of integrative physiology of the human organism with pathophysiology. Select and interpret scientific data relevant to physiology and pathophysiology.

Programma

MODULE 1 (Prof. Chatzidimitrakis)
SENSORY SYSTEMS General principles of sensory coding. Perception. Neural coding of somatosensory stimuli. Somatosensory cortical areas. Psychophysics of tactile perception. Visual perception. Primary visual cortex: topographic organization and functional circuits. Visual maps, brain maps. SENSORIMOTOR INTEGRATION and VOLUNTARY MOVEMENTS Organization and functions of the dorsal visual stream. Lesions: optic ataxia, agnosia. Posterior parietal cortex: sensorimotor integration functions. Premotor and supplementary motor cortex. Primary motor cortex and movement control mechanisms. Motor disorders, motor prostheses.
CARDIOVASCULAR FUNCTION
RESPIRATORY FUNCTION
RENAL FUNCTION
General aspects of renal function: ultrafiltration, secretion, reabsorption. Ultrafiltration process: pressure balance and effective filtration pressure. Ultrafiltration rate. Antidiuretic hormone. Aldosterone and the renin-angiotensin system.
[http://www.unibo.it/it/didattica/insegnamenti/insegnamento/2021
MODULE 2 (Dr. Giorgio Medici)
NERVOUS SYSTEM DEVELOPMENT
Embryonic origin of the nervous system. Neurulation and neural tube formation. Dorsoventral and rostrocaudal patterning. Neurogenesis, gliogenesis, and neuronal differentiation. Cell migration, synapse formation, programmed cell death, and synaptic pruning. Role of neuronal activity in the maturation and plasticity of neural circuits.
THE ENTERIC NERVOUS SYSTEM AND THE GUT–BRAIN AXIS
Anatomical and functional organization of the enteric nervous system. Embryonic development of the enteric nervous system and the role of neural crest cells. Neural regulation of gastrointestinal function. Bidirectional communication between the gut and the brain. Role of the gut microbiota in the physiology of the gut–brain axis. Physiological and pathophysiological implications in neurological and neurodevelopmental disorders.
HUMAN MODELS FOR STUDYING PHYSIOLOGY AND NEURODEVELOPMENT
Induced pluripotent stem cells (iPSCs) and their applications in the study of human physiology. Brain organoids as three-dimensional model of human brain development and function. Applications, strengths, and limitations of organoid models in physiology and translational research.
MODULE 3 (Dr. Giorgio Medici)
Module 3 focuses on the applied part of the course and consists of four days of laboratory work. The module is split into morning and afternoon sessions, and students will be divided into two groups to facilitate better use of the activities. Each laboratory day begins with a lecture in the classroom to introduce the laboratory experience and present the day's activities. The laboratory work will focus on neurogenesis; specifically, students will learn how to perform immunolabeling to detect and quantify hippocampal neurogenesis in the mouse brain.
Pre-requisites
Participation in this educational activity requires all students to complete specific health and safety training for study environments (Modules 1, 2, and 3) in a hybrid format (e-learning and in-person). Detailed information is available on the course webpage under the section “Studying – Health and Safety mandatory training”.
[http://www.unibo.it/it/didattica/insegnamenti/insegnamento/2021/445293]

Modalità d'esame

Assessment Methods
The final assessment for the Physiology module is based on a written “true or false” multiple-choice test covering topics presented during the lectures. This evaluation is conducted jointly with the assessments for the other modules included in the Integrated Course “Anatomical and Physiological Bases of Organ Pathologies”, and a single final grade is assigned for the entire Integrated Course.
Students with learning disorders and\or temporary or permanent disabilities: please, contact the office responsible (https://site.unibo.it/studenti-con-disabilita-e-dsa/en/for-students) as soon as possible so that they can propose acceptable adjustments. The request for adaptation must be submitted in advance (15 days before the exam date) to the lecturer, who will assess the appropriateness of the adjustments, taking into account the teaching objectives.

Testi di riferimento

Kandel ER, Jessell TM, Schwartz JH, Siegelbaum SA, Hudspeth AJ. Principles of Neural Science, 5th ed. Mc Graw-Hill Purves D, et al., Neurosciences, 6th ed. Sinauer Associates Vander et al., Human Physiology: The Mechanism of Body Function; 8th ed; McGraw−Hill Articles and reviews will be provided to supplement these texts.

Codice insegnamento 76149

Stem Cell Therapy 1° anno · 2° semestre · 4 CFU · BIOS-13/A · 0 file

Identify and discuss stem cell features, molecular mechanisms of differentiation and possible applications related to regenerative medicine. Recognise the characteristics of embryonic stem cells and those of the adult…

Scheda dell'insegnamento

Obiettivi formativi

Identify and discuss stem cell features, molecular mechanisms of differentiation and possible applications related to regenerative medicine. Recognise the characteristics of embryonic stem cells and those of the adult stem cells. Describe the methods for stem cell isolation to obtain progenitor cells from extraembryonic tissues.​

Programma

Frontal lessons (3 UC)
Mesenchymal Stem Cells (MSCs): historical background, isolation, immunophenotypic characterization, differentiation ability, trophic and immunomodulatory features.
Alternative source and clinical perspectives of MSCs.
Embryonic Stem Cells (ESCs) and induced Pluripotent Stem Cells (iPSCs).
Resident angiogenic mesenchymal stem cells from heart-beating multiorgan donors
Stem cells for the regeneration of chondrogenic and osteogenic.
The regeneration of the skin. The stem cell niches of epithelial stem cells.
3D Organoid System: 3D Scaffold application in cell culture and organoid models: tissue engineering approach for disease modelling and regenerative medicine approaches.
Cell Culture Laboratory for studying stem cells.
Lab work experience (1 UC)
1- Demonstration of human term placenta. Human mesenchymal cell isolation from the Wharton's jelly of the umbilical cord;
2 - Isolation of epithelial cells from the amniotic membrane;
3 - Isolation of mononuclear cells from blood and preparation of a co-culture to evaluate the immunomodulatory action of the epithelial cells isolated from amniotic membrane;
4 - Evaluation of the cycle phases of mononuclear cells maintained in co-cultured with epithelial cells of the amniotic membrane;
5 - Evaluation of perinatal cell differentiation potential by attempting an angiogenic assay based on a 3D semi-solid culture system.
Discussion of data and comparison with those reported by scientific literature.

Modalità d'esame

The purpose of the oral exam is to verify the students' ability to apply their knowledge and make the necessary logical-deductive connections, focusing on achieving the learning objectives relating to:

  • stem cell basics and classification
  • stem cell applications, cell therapy and tissue engineering
  • stem cell research and techniques
    Oral examination on two topics among a list of topics covered during the course.
    Regarding assessment, the use of AI is prohibited. Any such use constitutes a violation of academic integrity.
    The result is graduated from 18/30 to 30/30
    Lack of preparation, serious and repeated conceptual errors → <18
    Preparation on a very limited number of topics covered in the course and analytical skills that emerge only with the help of the teacher, expressed in an overall correct language → 18-19;
    Preparation on a limited number of topics covered in the course and ability to perform autonomous analysis only on purely executive matters, expression in correct language → 20-24;
    Preparation on a large number of topics covered in the course, ability to make independent choices of critical analysis, mastery of specific terminology → 25-29;
    Exhaustive preparation on the topics covered in the course, ability to make autonomous choices of critical analysis and connection, full mastery of specific terminology, and ability to argue and self-reflection → 30-30L.
    The final mark of the "Stem Cell Therapy" course will be mediated with the marks reported in the “Human Embryology course and with the “Molecular Basis of Haematological Disorders” course.
    To access the exam, online booking on Almaesami before the exam is mandatory
    For students with learning disabilities (LD) or temporary or permanent disabilities: we recommend contacting the competent university office [https://site.unibo.it/studenti-con-disabilita-e-dsa/en/for-students] promptly; they will be responsible for suggesting any specific adaptation. All issues must, however, be submitted 15 days in advance for approval by the instructors, who will evaluate the appropriateness of the request, also taking into account the educational objectives of the course
    Regarding learning assessment, the use of AI is prohibited. Any such use constitutes a violation of academic integrity

Testi di riferimento

Recommended Textbook: G.P. Bagnara, Stem Cells, Ed. Esculapio.
Recommended scientific papers given during the lessons.

Codice insegnamento 90935

BIOSTATISTICS 2° anno · 3 CFU · STAT-01/A · 0 file

Al termine del corso, lo studente conosce le tecniche statistiche applicate. Oltre ad acquisire nozioni elementari di statistica descrittiva, lo studente comprende la logica dell’inferenza statistica, sapendo applicare i…

Scheda dell'insegnamento

Obiettivi formativi

Al termine del corso, lo studente conosce le tecniche statistiche applicate. Oltre ad acquisire nozioni elementari di statistica descrittiva, lo studente comprende la logica dell’inferenza statistica, sapendo applicare i test statistici più diffusi nella ricerca e nella professione. Sa inoltre effettuare analisi statistiche con programmi dedicati, e sa interpretare l’output nel contesto del fenomeno o dell’esperimento analizzato.

Programma

The course introduces fundamental and intermediate statistical methods, with applications to biomedical engineering. Topics include:
Biomedical data, types of variables and measurement scales Experimental and observational study designs, bias, confounding and causal interpretation Contingency tables, risk measures, odds ratios and Simpson’s paradox Descriptive statistics, data visualization and exploratory data analysis Probability, probability distributions and diagnostic test evaluation Sampling distributions, estimation and confidence intervals Hypothesis testing, effect sizes, statistical power and practical significance Simple and multiple linear regression, including confounding, interactions and model diagnostics Logistic regression for binary outcomes Analysis of variance and comparison of multiple groups Time-to-event data and survival analysis Poisson and negative binomial regression for count data Introductory cluster analysis
Real and realistic biomedical datasets will be used throughout the course. Emphasis will be placed on statistical reasoning, selection of appropriate methods, interpretation of results, and assessment of model assumptions. All analyses will be conducted using R.

Modalità d'esame

Assessment consists of a final written examination including theoretical questions, applied exercises and the interpretation of statistical analyses and R output.
The examination assesses the student’s ability to select an appropriate statistical method, explain the underlying assumptions, perform or interpret the analysis, and communicate conclusions in the context of a biomedical problem.
Studenti/sse con DSA o disabilità temporanee o permanenti: si raccomanda di contattare per tempo l’ufficio di Ateneo responsabile (https://site.unibo.it/studenti-con-disabilita-e-dsa/it): sarà sua cura proporre agli/lle studenti/sse interessati/e eventuali adattamenti, che dovranno comunque essere sottoposti, con un anticipo di 15 giorni, all’approvazione del/della docente, che ne valuterà l'opportunità anche in relazione agli obiettivi formativi dell'insegnamento.

Testi di riferimento

Main textbook
Wayne W. Daniel and Chad L. Cross, Biostatistics: A Foundation for Analysis in the Health Sciences, 11th Edition, Wiley.
This is the main reference textbook for probability, statistical inference, analysis of variance, linear and generalized linear models, analysis of categorical data and survival analysis. Specific chapters and sections will be indicated during the course.
Supplementary reference
Ronald N. Forthofer, Eun Sul Lee and Mike Hernandez, Biostatistics: A Guide to Design, Analysis, and Discovery, 2nd Edition, Academic Press.
Selected sections will be used to complement the main textbook, particularly for study design, data quality, bias, confounding and interpretation of biomedical studies.
Additional materials and R scripts for topics not fully covered by the main textbook will be provided through the course platform.

Codice insegnamento 28172

Clinical Laboratory Diagnostics 2° anno · 5 CFU · MEDS-02/B · 0 file

Describe the theoretical and methodological bases of cytology, cytopathology, immunohematology and genetic pathology. Discuss the application of cellular and molecular methodological approaches to the diagnostic…

Scheda dell'insegnamento

Obiettivi formativi

Describe the theoretical and methodological bases of cytology, cytopathology, immunohematology and genetic pathology. Discuss the application of cellular and molecular methodological approaches to the diagnostic process in human pathology. Interpret the results of diagnostic laboratory tests for the characterisation of major human disorders.

Programma

(Modulo 1)
PRINCIPI DI INTERPRETAZIONE DEI DATI DI LABORATORIO
Variabilità diagnostica e biologica, precisione e accuratezza, sensibilità e specificità, errori e controllo dei metodi negli esami clinici di laboratorio; intervalli di riferimento.
TEST DI SCREENING NEONATALE
Principi e principali applicazioni per fenilchetonuria, ipotiroidismo congenito, fibrosi cistica, galattosemia, screening allargato.
IL LABORATORIO ANALISI IN EMATOLOGIA
Emopoiesi; globuli rossi: fisiologia e patologia (anemie, emoglobinopatie); Piastrine e leucociti; definizione e modalità di valutazione di: ematocrito, eritrociti, emoglobina, MCV, MCH, MCHC, RDW e conteggio reticolociti. Parametri di laboratorio per la diagnosi delle anemie. Parametri di valutazione del metabolismo del ferro, ferritina, transferrina, sideremia.
IL LABORATORIO NELLA VALUTAZIONE DELLA FUNZIONALITA' RENALE
Esame completo delle urine (chimico-fisico e morfologico). Marcatori della funzionalità renale: creatinina, clearance della creatinina, azotemia, acido urico, elettroliti.
IL LABORATORIO NELLA VALUTAZIONE DELLA FUNZIONALITA' EPATICA
Esami di primo livello per la valutazione della funzionalità epatica. Marcatori del profilo epatico: colestasi, citolisi, protidosintesi.
TESTGENETICI
Tecniche biochimiche (per fibrosi cistica, fenilchetonuria, talassemie), Tecniche molecolari:
1. Test genetici indiretti (polimorfismi di lunghezza, SNP); 2. Test genetici diretti (Tecniche per la ricerca di mutazioni note, Tecniche per la ricerca di mutazioni non note). Applicazioni diagnostiche NGS, Pannelli / esoma clinico. NIPT
BIOPSIA LIQUIDA E RICERCA DI MATERIALE TUMORALE CIRCOLANTE: cellule, DNA ed RNA
(Modulo 2)

  • Il laboratorio nella valutazione della funzione emostatica.Indagini di laboratorio per la valutazione della funzionalità piastrinica, della fase plasmatica della coagulazione e del sistema fibrinolitico; indagini di laboratorio per la definizione degli stati di ipercoagulabilità. Fisiopatologia della CID; indici di attivazione del sistema della coagulazione; indici di attivazione del sistema fibrinolitico; indici di consumo dei fattori della coagulazione.
  • Le proteine sieriche. Separazione elettroforetica delle proteine sieriche; profili elettroforetici associati a patologie specifiche; proteine della fase acuta e velocità di eritrosedimentazione (VES). Proteine sieriche indici di infiammazione.
    Medicina trasfusionale. Determinazione dei gruppi sanguigni. Le prove pre-trasfusionali. Complicanze delle trasfusioni. Test molecolari in medicina trasfusionale

Modalità d'esame

L'esame finale consiste in una serie di 40 domande a risposta multipla (4 risposte possibili, di cui una sola corretta) che copriranno tutti gli argomenti del corso (con un numero di domande sui vari argomenti proporzionale al numero dei CFU di ciascun insegnamento/modulo). L'esame si considererà superato (con punteggio di 18) quando ad almeno 22 domande sarà data una risposta corretta. Il voto di 30 e lode verrà assegnato nel caso in cui tutte le risposte alle domande siano corrette.

Testi di riferimento

Laboratory Medicine Diagnosis of Disease in Clinical Laboratory - Michael Laposata. McGraw-Hill, 2014. ISBN 9780071805544

Codice insegnamento 90940

Clinical Microbiology 2° anno · 5 CFU · MEDS-03/A · 0 file

Explain interactions between opportunistic and pathogenic microorganisms and susceptible hosts in contacts that result in infection and/or disease and apply these interactions to disease symptoms. Demonstrate an…

Scheda dell'insegnamento

Obiettivi formativi

Explain interactions between opportunistic and pathogenic microorganisms and susceptible hosts in contacts that result in infection and/or disease and apply these interactions to disease symptoms. Demonstrate an appreciation and understanding of clinical laboratory skills and techniques related to the isolation, staining, identification, assessment of metabolism, and control of microorganisms. Interpret and draw appropriate conclusions from laboratory results. Analyze and distinguish therapeutic treatments for microbial infections, and distinguish when a vaccine, antibiotic, or other therapy is likely to be the most appropriate response. Specify the role of ecology and evolution in the spread of infectious diseases, comparing the role of transmission, population size and susceptibility, and virulence in endemic disease, epidemic disease, emerging diseases, and bioterrorism.

Programma

Diagnosi di laboratorio delle patologie infettive: metodi e valore clinico del dato microbiologico. Microbiologia delle infezioni delle alte e basse vie respiratorie e infezioni nel paziente immunocompromesso.
Microbiologia delle infezioni dell’apparato gastro-enterico ed intraddominali. Epatiti Virali.
Microbiologia delle infezioni delle vie urinarie. MTS
Microbiologia delle infezioni di cute, ossa e articolazioni. Infezioni delle protesi articolari
Microbiologia delle infezioni dell’apparato cardiocircolatorio e sepsi Microbiologia delle infezioni del sistema nervoso centrale Microbiologia delle Zoonosi

Modalità d'esame

La verifica dell’apprendimento avviene attraverso un esame finale che accerta l’acquisizione delle conoscenze attese tramite lo svolgimento di una prova orale. Tale prova mira a valutare la capacità di riconoscere e discutere le principali tecniche di analisi impiegate nella diagnostica di laboratorio della patologia infettiva nonché di avere acquisito le conoscenze essenziali per la l'interpretazione dei risultati di laboratorio. Sarà inoltre valutata la capacità dello studente di identificare il corretto ed appropriato percorso diagnostico per ogni specifica situazione clinica di infezione.
Gradazione del voto finale:
preparazione su un numero molto limitato di argomenti affrontati nel corso e capacità di analisi che emerge solo con l’aiuto del docente, espressione in linguaggio complessivamente corretto → 18-19; preparazione su un numero limitato di argomenti affrontati nel corso e capacità di analisi autonoma solo su questioni puramente esecutive, espressione in linguaggio corretto → 20-24; preparazione su un numero ampio di argomenti affrontati nel corso, capacità di compiere scelte autonome di analisi critica, padronanza della terminologia specifica → 25-29; preparazione esaustiva sugli argomenti affrontati nel corso, capacità di compiere scelte autonome di analisi critica e di collegamento, piena padronanza della terminologia specifica e capacità di argomentazione e autoriflessione → 30-30L.
Ad ogni candidato verranno formulate non meno di due domande.
Nel caso in cui lo studente ne facesse richiesta verrà posta una terza domanda. Il voto finale corrisponderà alla media dei voti ottenuti nelle singole domande.

Testi di riferimento

Patrick Murray, Ken Rosenthal & Michael Pfaller. Medical Microbiology. 9th edition. Elsevier 2020.
Paperback ISBN: 9780323673228
eBook ISBN: 9780323674508

Codice insegnamento 76209

Gene Therapy 2° anno · 5 CFU · MEDS-02/A · 0 file

Define the main technologies of gene transfer and compare them in terms of therapeutic approaches, efficiency and safety. Explain inherited and acquired diseases that could benefit from gene therapy. Discuss the…

Scheda dell'insegnamento

Obiettivi formativi

Define the main technologies of gene transfer and compare them in terms of therapeutic approaches, efficiency and safety. Explain inherited and acquired diseases that could benefit from gene therapy. Discuss the regulatory aspects related to gene therapy. Choose the gene therapy approach that fits each disease, and evaluate its advantages and disadvantages. Critically evaluate features, innovation, safety of reports on gene therapy studies. Keep up-to-date on rules, methods, technologies and devices, through scientific literature, gene therapy websites and data banks.

Programma

Introduzione alla terapia genica.
Fonti di documentazione.
Introduzione al trasferimento genico.
Targeting trasduzionale; Targeting trascrizionale; Promotori inducibili e tessuto/tumore-specifici.
Genome editing con CRISPR-Cas.
Laboratorio 1: strumenti informatici per l'utilizzo di CRISPR-Cas.
Vettori virali per la terapia genica: adenovirus, virus adeno-associati e retrovirus.
Trasduzione genica con metodi non virali.
Strategie ablative: oligonucleotidi antisenso; RNA interference; ribozimi.
Uso terapeutico di non-coding RNA.
Principali applicazioni di terapia genica delle malattie ereditarie monogeniche.
Terapia genica e terapia cellulare dei tumori.
Aspetti etico-giuridici della terapia genica somatica, fetale e della linea germinale.
Laboratorio 2: lavoro di gruppo e dibattito in aula su aspetti controversi della terapia genica.

Modalità d'esame

L’apprendimento verrà valutato tramite una prova orale.
Se lo studente ha partecipato alle attività in classe, il voto ottenuto da queste attività contribuisce al raggiungimento del voto finale.
Il voto finale sarà frutto della media, pesata sui CFU, dei voti dei singoli insegnamenti del C.I. TERAPIE MEDICHE INNOVATIVE.
Il voto minimo per superare l’esame è di 18/30.

Testi di riferimento

Articoli originali di ricerca e review forniti dal docente in formato .pdf
Presentazioni didattiche fornite in formato .pdf
Giacca, Terapia genica, Springer 2011
Chapters from Strachan, Genetics and Genomics in Medicine, Garland Science (ed. Italiana Zanichelli)

Codice insegnamento 76211

INTERNSHIP 2° anno · 4 CFU · 0 file

At the end of the internship the student acquires a direct knowledge of a working environment coherent with his/her studies in Green Quantitative finance. The student has the comprehension of the organization he/she's…

Scheda dell'insegnamento

Obiettivi formativi

At the end of the internship the student acquires a direct knowledge of a working environment coherent with his/her studies in Green Quantitative finance. The student has the comprehension of the organization he/she's working in and she/he is able to adapt himself/herself to the structure. She/He is able to relate himself/herself with management, colleagues, clients and other public interlocutors.

Programma

The internship must be strictly related to the main topic of the master and to the final thesis.

Codice insegnamento 98779

In Vivo Neurometabolic Diagnostics 2° anno · 5 CFU · BIOS-09/A · 0 file

Describe the main diagnostic metabolic and functional imaging techniques for in vivo investigation of neurological disorders.

Scheda dell'insegnamento

Obiettivi formativi

Describe the main diagnostic metabolic and functional imaging techniques for in vivo investigation of neurological disorders.

Programma

The course will focus on advanced MRI techniques for the study of central nervous system (CNS) diseases.
1. Introduction to the basics of MR spectroscopy (MRS), diffusion tensor imaging (DTI), and functional MRI (fMRI) techniques
2. Discussion of the advanced MRI following CNS disorders:

  • Brain tumors, primary and metastatic
  • Inflammatory diseases: infective and autoimmune
  • Metabolic diseases
  • Neurodegenerative diseases
    3. Basics of radiogenomics

Modalità d'esame

L’esame finale orale consiste nella verifica del raggiungimento degli obiettivi (pensiero critico, conoscenza degli argomenti) nell’ambito del Corso integrato “Neurological, Psychiatric Diseases and Pain (I.C.)”.
La valutazione relativa alla prova d'esame di “In vivo Neurometabolic Diagnostics” verterà sugli argomenti affrontati a lezione.
SESSIONI D'ESAME
Per ragioni logistiche il Corso Integrato è composto da 2 moduli.
Modulo A (Psichiatria, Psicologia clinica, Neuropsicofarmacologia, Anestesiologia e gestione del dolore; CFU totali= 7):
19.01.26
16.02.26
30.03.26 (sessione straordinaria)
08.06.26
13.07.26
07.09.26
Le sessioni si terranno alle ore 15:00 – Viale Carlo Pepoli 5.
Modulo B (Neurologia, Neuroradiologia, Diagnostica neurometabolica in vivo, Neuropatologia, Neurochirurgia; CFU totali= 8):
22.01.26
19.02.26
31.03.26 (sessione straordinaria)
11.06.26
16.07.26
10.09.26
Le sessioni si terranno alle ore 9:00 – Ospedale Bellaria, Padiglione G, primo piano
VOTO FINALE
E’ obbligatorio sostenere l'esame del modulo B solo dopo aver superato il modulo A.
Al termine di ciascun modulo, la Commissione valuterà complessivamente le prove degli studenti secondo lo schema seguente:
o Eccellente 30/30L: preparazione completa, consolidata e accurata degli argomenti trattati nel corso integrato. Abilità a strutturare velocemente l’argomento. Abilità ad analizzare e connettere in maniera indipendente i diversi temi. Concetti espressi in giusta sequenza con piena padronanza dei termini specifici elaborati in maniera originale dallo studente.
o Ottimo 29-30/30: preparazione completa, consolidata e accurata degli argomenti trattati nel corso integrato. Abilità a strutturare velocemente l’argomento. Abilità ad analizzare e connettere in maniera indipendente i diversi temi d’esame. Concetti espressi in giusta sequenza con piena padronanza dei termini specifici.
o Molto buono 27-28/30: preparazione di ottimo livello, ma con imprecisioni significative nella presentazione che compromettono l’ottenimento del voto massimo. Abilità ad analizzare e collegare i temi d’esame in maniera indipendente. Esposizione dei concetti in giusta sequenza e con termini appropriati.
o Buono 23-26/30: preparazione di buon livello, ma con imprecisioni importanti nella presentazione. Abilità ad analizzare e collegare il discorso con il supporto del docente. Esposizione dei concetti in giusta sequenza e con termini appropriati.
o Sufficiente 18-22/30: conoscenza limitata ai concetti di base senza che vi siano lacune importanti. Abilità ad analizzare il discorso solo dopo il supporto del docente. Esposizione dei concetti e dei termini accettabile nel suo complesso.
o Insufficiente <18/30: preparazione scarsa. Presenza di importanti e ripetuti errori di concetto.
La verbalizzazione del voto finale (da 18/30 a 30/30) è possibile solo quando lo studente ha superato entrambi i moduli e sarà effettuata nel corso della sessione d'esame del modulo B di giovedì.
Lo studente è libero di accettare o rifiutare il voto finale comunicando la decisione.
Se uno studente non supera il modulo B potrà ripetere l'esame solo per il suddetto modulo mantenendo la valutazione positiva ottenuta nel modulo A, purché ciò avvenga entro lo stesso anno accademico (ultimo appello: 18.09.25). Se uno studente non ha completato tutti gli esami del corso integrato entro l'anno accademico, dovrà ripetere entrambi i moduli.

Testi di riferimento

The teaching material provided on the Virtuale platform (lesson slides, videos, scientific papers) are essential for exam preparation.
Further reading: inherent books available at Neuroimaging Lab, IRCCS Institute of Neurological Sciences, Bellaria Hospital (Pavillion A, ground floor) via Altura 3, Bologna.

Codice insegnamento 84437

Innovative Medical Therapies (I.C.) 2° anno · BIOS-11/A · 0 file

Identify key parameters for risk/benefit assessment of drug therapies. Understand sources of variability in clinical drug responses (including pharmacogenomics). Describe the basic methodology of pre-clinical and…

Scheda dell'insegnamento

Obiettivi formativi

Identify key parameters for risk/benefit assessment of drug therapies. Understand sources of variability in clinical drug responses (including pharmacogenomics). Describe the basic methodology of pre-clinical and clinical drug trials, their regulatory and ethical implications, and procedures for marketing authorization, with special reference to biotechnological drugs. Present therapeutic options (conventional and biotech drugs) in the context of a given disease, highlighting innovative aspects. Critically evaluate research articles presenting pre-clinical and clinical data, through consultation of specific databases and documentation provided online by regulatory agencies.

Programma

INTRODUCTION TO PHARMACOLOGY
Definition of drugs and medicinal products, with a focus on advanced therapy medicinal products (ATMPs). Evaluation of the efficacy and safety of a drug; adverse drug reactions Concept of General Pharmacology: Pharmacokinetics and pharmacodynamics Concept of innovative drug. Biotech medicines: classification, pharmacokinetic characteristics, pharmacodynamic and toxicological.
PHARMACOGENOMICS
The variability factors in drug response in individual and in a population. Definition of pharmacogenetics and pharmacogenomics. Examples of applications of pharmacogenetic tests.
PRECLINICAL DRUG TESTING
Basic statistical analysis in preclinical study: mean, median, distribution (parametrical and non-parametrical), t-test, one- and two-ANOVA, MANOVA, non-parametrical analysis Definition of in vitro experimentation, ex vivo, in vivo. Definition, use, development and ethics of animal models for preclinical testing. Genetic models for the development of new drugs. Concept of 3R and outline of the three-dimensional cell culture models for the replacement of the animal studies
THE CLINICAL EVIDENCE OF DRUGS
Classification and sources of information related to drugs. The phases of clinical development; the concept of randomized controlled trial: scientific aspects; the use of surrogate and clinical endpoints, ethical aspects of placebo; The concept of real-world evidence and the role of pharmacovigilance Principles of benefit-risk and cost-benefit assessment: bias, number needed to treat/harm, types of pharmacoeconomic studies; managed entry agreements. The role of systematic review and meta-analysis. Critical analysis of the innovation of biotechnological products.
REGULATORY ASPECTS
The authorization for a clinical trial: molecules of the new institution (the concept of first-in-class drug) and not to the new institution (drug repurposing). The role of ethics committees. The marketing authorization; centralized procedure and mutual recognition (decentralized): EU directives, with particular reference to biotechnological products; Roles of the European Medicines Agency (EMA) and the Italian Drug Agency (AIFA). Orphan drugs.

Modalità d'esame

The final examination consists of an oral dissertation concerning a single medicinal product (or a drug class) selected from a list agreed every year during the lectures. The time allowed for the presentation is 15 minutes maximum + 5 min questions. Use of original slides, specifically prepared by the student, is allowed during the presentation. During the presentation,student should be able to demonstrate that she/he has acquired the ability to critically analyze the chosen topic in at least four of the following areas: - Use of experimental models (n vivo, ex vivo and in vitro) for the study of drugs - Regulatory aspects relating to the preclinical and clinical testing of medicines (with particular reference to biotechnological medicines and advanced therapy medicines) and to the procedures necessary to obtain marketing authorization; - Evaluation of the risk / benefit ratio of drug therapies by identifying the correct sources of documentation; - Evaluation of the cost / benefit ratio of drug therapies, identifying adequate sources of information; - Identification of the variability factors implicated in the clinical response to drugs (including pharmacogenomics); - Identification of the innovative aspects of a medicine within a given therapeutic indication; - Identification of ethical issues related to preclinical and clinical trial projects for medicines.
Gradation of the final grade
The presentation will receive a score for each of the following aspects:
clarity and style of the presentation completeness of coverage of the four selected items (taking into account the time limit indicated above) critical assessment by the student of the selected sources of information
Final grades will be assigned according as follows:
o Outstanding (30L): full achievement of the learning outcomes. The presentation is clear, in professional style with no significant inaccuracies. When asked on specific aspects of the presentation, the student shows ability to promptly frame the topic and full understanding of the underlying theoretical concepts presented during the lessons. Ability to analyze and connect independently the different topics. Concepts in the right succession with some original elaboration by the student and full command of the specific language.
o Excellent (29-30): full achievement of the learning outcomes. The presentation is clear, in professional style with only minor inaccuracies. When asked on specific aspects of the presentation, the student shows ability to frame the topic and full understanding of the underlying theoretical concepts presented during the lessons. Ability to analyze and connect independently the different topics. Concepts in the right succession with some original elaboration by the student and full command of the specific language.
o Very good (27-28): very good level of achievement of the learning outcomes. The presentation is clear, in professional style although with some inaccuracies. When asked on specific aspects of the presentation, the student shows ability to frame the topic and adequate understanding of the underlying theoretical concepts presented during the lessons. Ability to analyze and connect independently the different topics. Concepts in the right succession with very good command of the specific language.
o Good (23-26): good level of achievement of the learning outcomes. The presentation may be clear, but with some significant inaccuracies. When asked on specific aspects of the presentation, the student shows good understanding of the underlying theoretical concepts presented during the lessons. Concepts are presented in the right succession with good command of the specific language. Ability to analyze and link concepts after input from the teacher.
o Sufficient (18-22): sufficient level of achievement of the learning outcomes. The presentation is unclear in the way it is presented and shows some significant inaccuracies/errors. When asked on specific aspects of the presentation, the student shows sufficient understanding of the underlying theoretical concepts presented during the lessons. Exposition of concepts and language acceptable as a whole.
o Insufficient (<18): failure to achieve the learning outcomes. The presentation is unclear in the way it is presented and shows several errors. When asked on specific aspects of the presentation, the student shows insufficient understanding of the underlying theoretical concepts presented during the lessons. Serious and repeated conceptual errors.
The mark obtained in this test contributes to the formation of the final mark of the Innovative Medical Therapies exam in proportion to the credits assigned to the Pharmacology module.
Students with learning difficulties and temporary or permanent disabilities are invited to contact the dedicated office (https://site.unibo.it/studenti-con-disabilita-e-dsa/it/per-studenti) as soon as possible so that appropriate compensatory measures can be agreed upon. The request must be submitted in advance (15 days before the exam date) to the teacher, who will assess the appropriateness of the measures, taking into account the educational objectives.

Testi di riferimento

It is not necessary to purchase specific texts. Updated teaching materials will be provided in class.

Codice insegnamento 90941

Laboratory Diagnostics (I.C.) 2° anno · 0 file

Define the general characteristic of bacteria, viruses, protozoa, fungi and helminths Describe the routes of transmission for infections of medical importance Discuss the establishment of host-parasite interaction…

Scheda dell'insegnamento

Obiettivi formativi

Define the general characteristic of bacteria, viruses, protozoa, fungi and helminths Describe the routes of transmission for infections of medical importance Discuss the establishment of host-parasite interaction Describe the basic concept of prophylaxis and antimicrobial and antiviral therapy, including mechanism of drug resistance Describe characteristics, pathogenesis, and clinical aspects for bacteria, viruses, protozoa, fungi and helminths of medical relevance Recognize and discuss the clinical meaning of microbiological findings within the diagnosis of infectious diseases.

Programma

1.Definitions of infection and infectious disease. Characteristics of bacteria of medical importance
2.Characteristics of viruses and protozoa of medical importance
3.Pathogenesis of infections and host defense
4.Prophylaxis of infections: immunoglobulines, monoclonal antibodies and vaccines
5. Microbiological diagnosis
6. Antibacterial drugs and antiviral drugs, mechanisms of drug resistance
7. Biotechnologies in the diagnosis of bloodstream infections
8. Biotechnology and human microbiota
9. Gram-positive cocci (staphylococci, streptococci)
10. Gram-negative cocci (neisserieaeceae) and Gram-positive rods (clostridia)
11. Gram-negative rods belonging to Enterobacteriaceae
12. Mycobacteria
13. Spirochetaes
14. Enteric protozoa. Other foodborne protozoa (Toxoplasma gondi)
15. Vector-borne protozoa: leishmaniasis, malaria
16. DNA viruses: Herpesviridae, Papillomaviridae
17. RNA viruses: Coronaviridae and influenza viruses
18. RNA viruses: retroviruses
19. RNA viruses: arboviruses
20.RNA viruses: hepatitis viruses

Modalità d'esame

Student learning will be checked at the end of the course through a written test divided into two parts. The first part consists in carrying out a test composed of 20 multiple choice questions with 4 possible answers, of which only one is correct; 1 point will be awarded for each correct answer, without any penalty in the event of a wrong or missing answer. The second part consists in the answer to two open questions, referring to each of the two course units (Clinical Laboratory Diagnostics and Clinical Microbiology). Each answer will be awarded from 0 to 6 points based on the candidate's ability to present the arguments in a correct, concise and complete way. The maximum time for performing the test will be 50 minutes. The student needs to reach 18 points to pass the exam. The final grade will be derived from the sum of the points acquired in both parts. The examination is passed having acquired at least 18 points. Honors will be awarded to candidates who have achieved a total of 31 or 32 points. To take the test, students will need to register via AlmaEsami by the deadline set by the application and are required to know their Institutional credentials.
The results will be published on Almaesami in the students' reserved area by a date specified for each exam session and indicated on Almaesami. Students who wish to reject the grade must notify the commission within 2 working days from the publication. In absence of any notification the exam results will be registered.
Students with Specific Learning Disorders (SLD) or temporary or permanent disabilities are strongly encouraged to contact the University's Disability and Specific Learning Disorders Support Service as early as possible: https://site.unibo.it/studenti-con-disabilita-e-dsa/en . The Service will assess individual needs and, where appropriate, propose reasonable accommodations. Any proposed accommodations must be submitted to the course teachers for approval at least 15 days before the scheduled assessment. The teachers will evaluate the appropriateness of the requested accommodations in relation to the intended learning outcomes and the educational objectives of the course.

Testi di riferimento

The lecture notes provided by the teachers on the UNIBO’s Virtuale platform constitute the required study material for the course.
Recommended reading: Patrick Murray, Ken S. Rosenthal, and Michael A. Pfaller. Medical Microbiology, 10th Edition, May 2025. Elsevier. Available at the University of Bologna Biomedical Library. This textbook is recommended as supplementary reading for students wishing to deepen their understanding of the topics covered in the course

Codice insegnamento 90939

Neurology 2° anno · 4 CFU · MEDS-12/A · 0 file

Describe the clinical manifestations, etiology, epidemiology, risk factors, natural history, diagnosis, staging, prognostic indicators and management of the major diseases of the nervous system, with emphasis on those…

Scheda dell'insegnamento

Obiettivi formativi

Describe the clinical manifestations, etiology, epidemiology, risk factors, natural history, diagnosis, staging, prognostic indicators and management of the major diseases of the nervous system, with emphasis on those most commonly encountered in the clinical practice. Identify the major diagnostic and therapeutic options for each encountered clinical scenario, and discuss their benefits and limitations. Summarize decision-making algorithms for a correct differential diagnosis, prognosis, and treatment choice. Present and critically analyze clinical cases, discuss the differential diagnosis, and formulate appropriate diagnostic and therapeutic strategies for each case (Problem-Based Learning).

Programma

Principali indagini neurofisiologiche:

  • Elettromiografia
  • Elettroencefalografia
  • Polisonnografia
    Nervi cranici
    Biomarkers biofluidi diagnostici e prognostici in neurologia
    Patogenesi e patologia molecolare delle malattie neurodegenerative
    Disfunzioni cognitive (afasia, aprassia, agnosia, amnesia, anomalie del comportamento)
    Declino cognitivo lieve e sindromi dementigene
    Malattie del motoneurone (SLA e SMA)
    Polineuropatie (acquisite ed ereditarie)
    Mononeuropatie
    Disturbi della giunzione muscolare (contratti e ereditari)
    Miopatie (acquisite ed ereditarie)
    Sindromi epilettiche.
    Disturbi del sonno
    Principali malattie demielinizzanti del sistema nervoso centrale e periferico
    Malattia di Parkinson
    Parkinsonismo atipico
    Disordini del movimento ipercinetici
    Demenze ed encefaliti a rapida progressione
    Disturbi cerebrovascolari
    Cefalea
    In relazione alle patologie sopra indicate, verranno tenuti in considerazione i seguenti argomenti: Definizione e classificazione; eziologia; patofisiologia; sintomi e segni; percorso diagnostico e diagnosi differenziale; principali trattamenti.

Modalità d'esame

L’esame finale orale consiste nella verifica del raggiungimento degli obiettivi (pensiero critico, conoscenza degli argomenti) nell’ambito del Corso integrato “Neurological, Psychiatric Diseases and Pain (I.C.)”
La valutazione riguardante l’esame di “NEUROLOGIA” verterà principalmente su argomenti affrontati a lezione.
Per ragioni logistiche il corso integrato è composto da 2 moduli:
Module A (Psychiatry, Clinical Psycology, Neuropsycopharmacology, Anaesthesiology and Pain Management; total 7 CFU):
18.01.27
15.02.27
22.03.27 (sessione straordinaria)
07.06.27
12.07.27
06.09.27
Exam sessions to be held at 3:00 p.m (afternoon) at Viale Carlo Pepoli 5.
Module B (Neurology, Neuroradiology, In vivo Neurometabolic Diagnostics, Neuropathology, Neurosurgery; total 8 CFU):
21.01.27
18.02.27
23.03.27 (sessione straordinaria)
10.06.27
15.07.27
09.09.27
Exam sessions to be held at 9:00 a.m. (morning) at Bellaria Hospital, Pavilion G, First Floor
VOTO FINALE:
E’ obbligatorio sostenere l'esame del modulo B solo dopo aver superato il modulo A
Al termine di ciascun modulo, la Commissione valuterà complessivamente le prove degli studenti secondo lo schema seguente:
o Eccellente 30/30L: preparazione completa, consolidata e accurata degli argomenti trattati nel corso integrato. Abilità a strutturare velocemente l’argomento. Abilità ad analizzare e connettere in maniera indipendente i diversi temi. Concetti espressi in giusta sequenza con pieno comando dei termini specifici elaborati in maniera originale dallo studente.
o Ottimo 29-30/30: preparazione completa, consolidata e accurata degli argomenti trattati nel corso integrato. Abilità a strutturare velocemente l’argomento. Abilità ad analizzare e connettere in maniera indipendente i diversi temi d’esame. Concetti espressi in giusta sequenza con pieno comando dei termini specifici.
o Molto buono 27-28/30: preparazione di ottimo livello, ma con imprecisioni significative nella presentazione che compromettono l’ottenimento del voto massimo. Abilità ad analizzare e collegare i temi d’esame in maniera indipendente. Esposizione dei concetti in giusta sequenza e con termini appropriati.
o Buono 23-26/30: preparazione di buon livello, ma con imprecisioni importanti nella presentazione. Abilità ad analizzare e collegare il discorso dopo l’aiuto dell’insegnante. Esposizione dei concetti in giusta sequenza e con termini appropriati.
o Sufficiente 18-22/30: conoscenza limitata ai concetti di base senza che vi siano lacune importanti. Abilità ad analizzare il discorso solo dopo l’aiuto dell’insegnante. Esposizione dei concetti e dei termini accettabile nel suo complesso.
o Insufficiente <18/30: preparazione scarsa. Presenza di importanti errori di concetto ripetuti.
La verbalizzazione del voto finale (da 18/30 in su) sarà effettuata quando lo studente ha superato entrambi i moduli nel corso della sessione del modulo B di giovedì. Lo studente è libero di accettare o rifiutare il voto finale comunicando la decisione.
Se uno studente non supera il modulo B potrà ripetere l'esame solo per il suddetto modulo mantenendo la valutazione positiva ottenuta nell'altro modulo A, purché ciò avvenga entro lo stesso anno accademico (ultimo appello 09.09.27). Se uno studente non ha completato tutti gli esami del corso integrato entro l'anno accademico, deve ripetere entrambi i moduli.

Testi di riferimento

Eleventh Edition
Adams and Victor's - Principles of Neurology
Allan H. Ropper
Martin A. Samuels
Joshua P. Klein
Sashank Prasad

Codice insegnamento 65155

Neurometabolic and Neurodegenerative Disorders (I.C.) 2° anno · 0 file

Discuss conventional and innovative technologies for the quantitative mapping of in vivo central nervous system and neuromuscular metabolic biomarkers. Describe in vivo neurometabolism in relationship to physiological…

Scheda dell'insegnamento

Obiettivi formativi

Discuss conventional and innovative technologies for the quantitative mapping of in vivo central nervous system and neuromuscular metabolic biomarkers. Describe in vivo neurometabolism in relationship to physiological and pathological conditions. Discuss the application of in vivo connectome imaging for the investigation of ageing and pathogenetic mechanisms, and for diagnostic, prognostic and follow-up purposes in pathological conditions. Develop expertise in the advanced processing and multi-level analyses of neurometabolic networks in line with the rapidly developing biomedical research and clinical settings. Develop skills for working in multidisciplinary team including clinicians, neuropsychologists, physicists, bioinformaticists and technicians.

Programma

Module 1 (Prof. Tonon)
Course introduction
In vivo metabolic investigation techniques of the central and peripheral nervous system Elements of acquisition and analysis of magnetic resonance data (brain proton MR spectroscopy, muscle phosphorus MR spectroscopy, diffusion tensor imaging, functional MRI, quantitative susceptibility mapping) Elements of nuclear medicine Application of in vivo metabolic-microstructural investigation methods to the main groups of pathologies of the nervous system (genetic, toxic-metabolic, degenerative, neoplastic and inflammatory)
Advanced analysis methods and tools: elements of connectome imaging and analysis and elements of machine learning methods for medical research
Principles of radiogenomics
Module 2 (Prof. Bacalini)
Module 2 will focus on the discovery and validation of biomarkers for brain aging. Specifically, the following topics will be discussed:
Biomarkers: definitions and characteristics; experimental design and statistical considerations in biomarkers discovery. Laboratory medicine: the pre-analytical, analytical and post-analytical phases Variability and standardization of laboratory testing Performance of a laboratory test: sensibility, specificity, predicting values and ROC curves Overview of aging and brain aging pillars; contribution of aging in neurodegenerative diseases. Omics for biomarkers discovery in the fields of aging and brain aging. Biomarkers of aging in anti-aging interventions.
Module 2 will include a laboratory devoted to the bioinformatic analysis of omic data for biomarkers discovery. In particular, a pipeline for the analysis of genome-wide and sequencing data related to brain aging, with a particular focus on DNA methylation, will be discussed and applied. Through the use of example-oriented exercises, the student will learn how to use R environment and Bioconductor packages to manage genomic data and answer biological questions
Module 3 (Prof. Morandi)
Course introduction Personalized medicine with examples in breast, lung, colorectal brain tumors DNA sequencing: from Sanger method to 2nd, 3rd and 4th generation sequencing Cloud computing tools for genomic assay designing Espansion repeat analysis using nanopore sequencing HLA genotyping using nanopore long read sequencing Principle of epigenetics: The use of genetic and epigenetic biomarkers in neurological disorders and tumours of the central nervous system The assessment of diagnostic, prognostic and predictive tests with examples from new assays based on Next Generation and nanopore Sequencing Clinical validation of a new diagnostic assay Tumor heterogeneity Liquid biopsy for diagnosis, prognosis and prediction of therapy through a minimally invasive technique Bioinformatic tools in clinical molecular biology: cloud computing approaches for NGS analysis identifying single point mutation, indels, genome rearrangements, copy number variations, variant allele frequency, gene fusions, epigenetic modifications, hierarchical clustering, principal component analysis, phylogenetic trees, methylation plot, ROC curves, Kaplan-Meier graph In Vitro Diagnostic Medical Device Regulation (IVDR) Wet lab practice: DNA purification; library preparation for Nanopore sequencing; loading libraries onto MinION platform; data analysis for expansion repeat disorders genetic biomarkers

Modalità d'esame

The exam consists of an oral interview with at least three questions covering the three main topics of the program.
Gradation of the final grade
Insufficient: lack of preparation. Serious and repeated conceptual errors.
18-19: knowledge of the basic concepts without serious gaps. Exposition of concepts and language as a whole acceptable.
20-24: knowledge of the basic concepts without gaps. Ability to analyze and link in partial autonomy. Exposure of discrete concepts and language.
25-29: preparation of good or very good level or even excellent preparation but with inaccuracies in the presentation that compromise the achievement of full marks. Ability to analyze and link independently. Exposure of concepts in the right succession and mastery of the language.
30-30L: full preparation, consolidated and without inaccuracies on the topics covered in the course. Ability to promptly frame the topic. Ability to analyze and connect independently. Concepts in the right succession and full command of the specific language.
The obtained grade will be the average (weighted average for credits) with that obtained in the integrated course of In vivo Neurometabolic diagnostics and Neurology.
Students with learning disorders and\or temporary or permanent disabilities: please, contact the office responsible (https://site.unibo.it/studenti-con-disabilita-e-dsa/en/for-students) as soon as possible so that they can propose acceptable adjustments. The request for adaptation must be submitted in advance (15 days before the exam date) to the lecturer, who will assess the appropriateness of the adjustments, taking into account the teaching objectives. With regard to assessment, the use of AI is prohibited. Any use constitutes a breach of academic integrity.

Testi di riferimento

Teaching materials in PDF available on https://virtuale.unibo.it

Codice insegnamento 90938

Pharmacology 2° anno · 2 CFU · BIOS-11/A · 0 file

Identify key parameters for risk/benefit assessment of drug therapies. Understand sources of variability in clinical drug responses (including pharmacogenomics). Describe the basic methodology of pre-clinical and…

Scheda dell'insegnamento

Obiettivi formativi

Identify key parameters for risk/benefit assessment of drug therapies. Understand sources of variability in clinical drug responses (including pharmacogenomics). Describe the basic methodology of pre-clinical and clinical drug trials, their regulatory and ethical implications, and procedures for marketing authorization, with special reference to biotechnological drugs. Present therapeutic options (conventional and biotech drugs) in the context of a given disease, highlighting innovative aspects. Critically evaluate research articles presenting pre-clinical and clinical data, through consultation of specific databases and documentation provided online by regulatory agencies.

Programma

INTRODUCTION TO PHARMACOLOGY
Definition of drugs and medicinal products, with a focus on advanced therapy medicinal products (ATMPs). Evaluation of the efficacy and safety of a drug; adverse drug reactions Concept of General Pharmacology: Pharmacokinetics and pharmacodynamics Concept of innovative drug. Biotech medicines: classification, pharmacokinetic characteristics, pharmacodynamic and toxicological.
PHARMACOGENOMICS
The variability factors in drug response in individual and in a population. Definition of pharmacogenetics and pharmacogenomics. Examples of applications of pharmacogenetic tests.
PRECLINICAL DRUG TESTING
Basic statistical analysis in preclinical study: mean, median, distribution (parametrical and non-parametrical), t-test, one- and two-ANOVA, MANOVA, non-parametrical analysis Definition of in vitro experimentation, ex vivo, in vivo. Definition, use, development and ethics of animal models for preclinical testing. Genetic models for the development of new drugs. Concept of 3R and outline of the three-dimensional cell culture models for the replacement of the animal studies
THE CLINICAL EVIDENCE OF DRUGS
Classification and sources of information related to drugs. The phases of clinical development; the concept of randomized controlled trial: scientific aspects; the use of surrogate and clinical endpoints, ethical aspects of placebo; The concept of real-world evidence and the role of pharmacovigilance Principles of benefit-risk and cost-benefit assessment: bias, number needed to treat/harm, types of pharmacoeconomic studies; managed entry agreements. The role of systematic review and meta-analysis. Critical analysis of the innovation of biotechnological products.
REGULATORY ASPECTS
The authorization for a clinical trial: molecules of the new institution (the concept of first-in-class drug) and not to the new institution (drug repurposing). The role of ethics committees. The marketing authorization; centralized procedure and mutual recognition (decentralized): EU directives, with particular reference to biotechnological products; Roles of the European Medicines Agency (EMA) and the Italian Drug Agency (AIFA). Orphan drugs.

Modalità d'esame

The final examination consists of an oral dissertation concerning a single medicinal product (or a drug class) selected from a list agreed every year during the lectures. The time allowed for the presentation is 15 minutes maximum + 5 min questions. Use of original slides, specifically prepared by the student, is allowed during the presentation. During the presentation,student should be able to demonstrate that she/he has acquired the ability to critically analyze the chosen topic in at least four of the following areas: - Use of experimental models (n vivo, ex vivo and in vitro) for the study of drugs - Regulatory aspects relating to the preclinical and clinical testing of medicines (with particular reference to biotechnological medicines and advanced therapy medicines) and to the procedures necessary to obtain marketing authorization; - Evaluation of the risk / benefit ratio of drug therapies by identifying the correct sources of documentation; - Evaluation of the cost / benefit ratio of drug therapies, identifying adequate sources of information; - Identification of the variability factors implicated in the clinical response to drugs (including pharmacogenomics); - Identification of the innovative aspects of a medicine within a given therapeutic indication; - Identification of ethical issues related to preclinical and clinical trial projects for medicines.
Gradation of the final grade
The presentation will receive a score for each of the following aspects:
clarity and style of the presentation completeness of coverage of the four selected items (taking into account the time limit indicated above) critical assessment by the student of the selected sources of information
Final grades will be assigned according as follows:
o Outstanding (30L): full achievement of the learning outcomes. The presentation is clear, in professional style with no significant inaccuracies. When asked on specific aspects of the presentation, the student shows ability to promptly frame the topic and full understanding of the underlying theoretical concepts presented during the lessons. Ability to analyze and connect independently the different topics. Concepts in the right succession with some original elaboration by the student and full command of the specific language.
o Excellent (29-30): full achievement of the learning outcomes. The presentation is clear, in professional style with only minor inaccuracies. When asked on specific aspects of the presentation, the student shows ability to frame the topic and full understanding of the underlying theoretical concepts presented during the lessons. Ability to analyze and connect independently the different topics. Concepts in the right succession with some original elaboration by the student and full command of the specific language.
o Very good (27-28): very good level of achievement of the learning outcomes. The presentation is clear, in professional style although with some inaccuracies. When asked on specific aspects of the presentation, the student shows ability to frame the topic and adequate understanding of the underlying theoretical concepts presented during the lessons. Ability to analyze and connect independently the different topics. Concepts in the right succession with very good command of the specific language.
o Good (23-26): good level of achievement of the learning outcomes. The presentation may be clear, but with some significant inaccuracies. When asked on specific aspects of the presentation, the student shows good understanding of the underlying theoretical concepts presented during the lessons. Concepts are presented in the right succession with good command of the specific language. Ability to analyze and link concepts after input from the teacher.
o Sufficient (18-22): sufficient level of achievement of the learning outcomes. The presentation is unclear in the way it is presented and shows some significant inaccuracies/errors. When asked on specific aspects of the presentation, the student shows sufficient understanding of the underlying theoretical concepts presented during the lessons. Exposition of concepts and language acceptable as a whole.
o Insufficient (<18): failure to achieve the learning outcomes. The presentation is unclear in the way it is presented and shows several errors. When asked on specific aspects of the presentation, the student shows insufficient understanding of the underlying theoretical concepts presented during the lessons. Serious and repeated conceptual errors.
The mark obtained in this test contributes to the formation of the final mark of the Innovative Medical Therapies exam in proportion to the credits assigned to the Pharmacology module.
Students with learning difficulties and temporary or permanent disabilities are invited to contact the dedicated office (https://site.unibo.it/studenti-con-disabilita-e-dsa/it/per-studenti) as soon as possible so that appropriate compensatory measures can be agreed upon. The request must be submitted in advance (15 days before the exam date) to the teacher, who will assess the appropriateness of the measures, taking into account the educational objectives.

Testi di riferimento

It is not necessary to purchase specific texts. Updated teaching materials will be provided in class.

Codice insegnamento 69888

Thesis 2° anno · 20 CFU · 0 file

The final examination consists of a dissertation written by the student under teachers supervision and its oral defense. The dissertation is an original study showing that the student is able to perform scientific…

Scheda dell'insegnamento

Obiettivi formativi

The final examination consists of a dissertation written by the student under teachers supervision and its oral defense. The dissertation is an original study showing that the student is able to perform scientific research individually and to report the study and its conclusions in a clear way. It likewise serves as a practice for those intending to pursue doctoral studies after their successful completion of the programme.

Codice insegnamento 27237

Classical and Next-Generation Genomics 1° semestre · 5 CFU · BIO/13 · 0 file
INTERNSHIP - Not available for the year 2025/2026 4 CFU · 0 file
Innovative Medical Therapies (I.C.) - Not available for the year 2025/2026 0 file
Laboratory Diagnostics (I.C.) - Not available for the year 2025/2026 0 file
Neurometabolic and Neurodegenerative Disorders (I.C.) - Not available for the year 2025/2026 0 file
Thesis - Not available for the year 2025/2026 20 CFU · 0 file

Recensioni del corso

Studi qui? Accedi per lasciare la tua recensione e aiutare altri studenti a scegliere.

★

Nessuna recensione per ora — e la prima è la più preziosa. Condividi la tua esperienza e orienta le future matricole.